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 Trypanosoma brucei maintains an infection in its mammalian host by 
switching its surface antigen, thus evading host antibodies, in a process known 
as antigenic variation.  Variant surface glycoproteins (VSG), the surface antigen, 
are expressed from genes located at as many as 20 Expression Sites (ES), 
which are present in subtelomeric regions of several chromosomes.  How 
trypanosomes maintain monoallelic expression of VSG is a major question in 
trypanosome biology.  Several theories have been proposed, including the 
presence of an Expression Site Body (a dedicated ‘transcription factory’), 
regulation of RNA elongation, and some kind of transcriptionally restrictive 
chromatin structure at inactive ES. 
 In other organisms, the role of histone posttranslational modifications 
(PTMs) in influencing transcriptional states has been well-documented.  To begin 
to understand the role of chromatin structure in the regulation of gene expression 
in trypanosomes, I developed a protocol for the purification of histones from 
mammalian-infective trypanosomes and identified PTMs using Edman 
degradation and mass spectrometry.  I found that the N-termini of H4 and, 
possibly, H3 have a number of posttranslational modifications (PTMs), while H2A 
and H2B, in contrast, have relatively few.  I also found a series of acetylated 
lysines at the C-terminus of H2A.  Interestingly, I observed that alanine 1 of H2A, 
H2B, and H4 is monomethylated, a novel modification found in trypanosomatids.   
 Next, I attempted to identify the targets of the putative histone deacetylase 
TbSIR2RP-1, a SIR2-related protein.  Yeast SIR2 plays a key role in establishing 
heterochromatin at subtelomeric loci.  TbSIR2RP-1 was chosen as a possible 
mediator of ES silencing, although this was later shown not to be the case.  I 
showed that, unlike its yeast counterpart, TbSIR2RP-1 may not be an H4 
deacetylase. 
 Finally, I began to characterize H3 K4 methylation, which, in other 
organisms, is traditionally associated with transcriptionally active chromatin.  I 
showed that nucleosomes containing the histone variant H2BV are enriched for 
H3 K4 methylation.  I initially hypothesized that this is due to ubiquitination at a 
conserved lysine at the H2BV C-terminus, but find that this is not the case.  
Instead, I propose that replacement of major histones H2A/H2B with H2AZ/H2BV 
acts as a trigger to stimulate H3 K4 methylation, which represents an alternative 
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 In eukaryotic organisms, the genome is packaged with proteins into a 
condensed structure in the nucleus known as chromatin.  The basic unit of 
chromatin is the nucleosome, formed by 146 bp of DNA wrapped around an 
octamer containing two copies of each of the core histones, H2A, H2B, H3, and 
H4.  Nucleosomes form “beads on a string,” and, with histone H1, form a 30 nm 
condensed fiber, which may be further condensed to form chromosomes.  The 
structure of chromatin was once thought to be static and inert, forming only a 
physical framework for DNA to be packaged in the nucleus.  Currently, the 
nucleosome is thought to be a dynamic structure that regulates the access of 
DNA to protein factors, influencing a variety of biological processes.  
Chromatin may be divided into euchromatin or heterochromatin.  
Heterochromatin is transcriptionally inactive, microscopically condensed, has 
relatively few ORFs, is rich in repetitive DNA, and is replicated late in S phase; 
euchromatin is transcriptionally active, uncondensed, rich in ORFs, and 
replicates early in S phase.  Understanding how these domains are formed and 
how the barriers between them are maintained are important fields of study in 
chromatin biology.     
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Histone Posttranslational Modifications 
 
Core histones contain many posttranslational modifications (PTMs), 
including phosphorylation, acetylation, methylation, and ubiquitination.  Histone 
PTMs influence a wide range of biological processes including transcriptional 
regulation and heterochromatin formation, nucleosome assembly, and DNA 
replication and repair [1].  These processes are mediated by the effector proteins 
that bind to modified histones [2].  Effector proteins with chromodomains bind 
methylated lysines [3-5], while proteins with bromodomains bind acetylated 
lysines [6-8]. 
Perhaps the most well-studied biological process affected by histone 
PTMs is gene expression.  Histone acetylation, for example, is generally 
associated with transcriptionally permissive chromatin, or euchromatin [9].  In 
Saccharomyces cerevisiae, chromatin immunoprecipitation was used to show 
that nucleosomes associated with actively transcribed genes were enriched for 
acetylated lysines at the H3 and H4 N-termini [10].  Histone acetylation affects 
transcription both by neutralizing the positive charge of lysines and by acting as a 
binding platform for effector proteins.  N-terminal acetylation is thought to disrupt 
interactions that stabilize the nucleosome, making the DNA more accessible to 
transcription-promoting complexes [11]. Also, acetylated lysines provide binding 
sites for a variety of effector proteins, including double bromodomain-containing 
human TAFII250 [12]. TAFII250, a subunit of the TFIID complex, binds 
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diacetylated H4, which allows for the recruitment of TFIID to sites of acetylation 
and subsequent assembly of the transcription initiation.  
Histone methylation also affects transcriptional activity of chromatin, but 
these effects are dependent on the particular lysine that is methylated: H3 K9 
and H4 K20 methylation are associated with silent chromatin, or heterochromatin, 
and H3 K4 and K79 methylation are associated with euchromatin [1].  The 
mechanisms by which methylated lysines promote transcription or induce 
heterochromatin formation are discussed. 
 
Establishment of Heterochromatin 
 
Two well-documented pathways illustrate the role of histone PTMs in 
heterochromatin formation.  In the first, mutations in suppressor of variegation 3-
9 (Su(var)3-9) and heterochromatin protein 1 (HP1) in Drosophila were shown to 
suppress position effect variegation, a phenomenon in which normally active 
genes may be silenced when placed in regions adjacent to heterochromatin, 
suggesting that the wild-type gene products were involved in heterochromatin 
formation [13,14].  In mammalian cells, Suv39h1, an Su(var)3-9 homologue, was 
shown be an H3 K9 histone methyltransferase (HMT) [15], which, in turn, creates 
a binding site for HP1 [3-5].  HP1 bound to methylated H3 K9 recruits a variety of 
factors including BRG1 [16], a chromatin remodeling factor that may generate 
heterochromatin, as well as Suv39h1 [17], thus propagating H3 K9 methylation 
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and heterochromatin assembly [16,18].  In addition to its role in establishing 
heterochromatin, HP1 is recruited to promoters in euchromatin for local gene 
silencing [19]. In Schizosaccharomyces pombe, H3 K9 methylation is dependent 
on Clr3, an H3 histone deacetylase (HDAC), demonstrating that multiple steps in 
the pathway leading to heterochromatin formation involve histone PTMs [20]. 
The constitutive heterochromatin assembly pathway involving H3 K9 
methylation is mediated by RNAi machinery [21,22].  In S. pombe, deletion of 
components of the RNAi machinery resulted in loss of H3 K9 methylation and de-
repression of reporter genes integrated into the centromere, indicating a role for 
RNAi in transcriptional repression by H3 K9 methylation [23].  Centromeric 
repeats are sufficient to nucleate heterochromatin formation [22].  Small RNAs 
are generated at centromeric repeats by RNAi machinery, which, in turn, are 
used to target the RITS (RNA-induced initiation of transcriptional gene silencing) 
complex to the centromere [21].  The RITS complex is thought to recruit Clr4, an 
H3 K9 HMT, as well as HDACs and other silencing factors.  Recuitment of Clr4 
results in the propagation of H3 K9 methylation and binding of Swi6, an HP1 
homologue.  The RITS complex also depends on H3 K9 methylation for binding 
through one of its components, chromodomain-containing Chp1.  The main 
regions of heterochromatin in S. pombe – the centromere, the mating-type loci, 
and the telomere – all produce small RNAs from their repetitive sequences, 
which are presumably used to nucleate heterochromatin assembly [24]. 
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In the second pathway, heterochromatin is established with the help of 
SIR (silent information regulator) proteins, which were first studied in S. 
cerevisiae.  The SIR2/3/4 complex is recruited to the telomere through the 
interaction of SIR4 with RAP1, a telomere binding protein [25-28].  SIR2 is an 
HDAC for K9 and K14 on H3 and K16 on H4 [29].  SIR2 plays a valuable role in 
the establishment of heterochromatin since SIR2 deletion mutants demonstrate 
defects in silencing at the telomere [30], the rDNA locus [31,32], and the mating 
loci [33].  SIR2 creates a binding platform for SIR3, which interacts with 
deacetylated H4 K16 [34,35], and recruits additional SIR4 and SIR2 to propagate 
heterochromatin assembly [36].  In this way, heterochromatin is nucleated at the 
telomere and propagates through the interaction of SIR proteins with the H3 and 
H4 N-termini [37,38].  In S. cerevisiae and other organisms, histone PTMs clearly 
play a role in determining whether chromatin is in a transcriptionally permissive or 
restrictive configuration. 
 
Chromatin Remodeling during Transcription Elongation 
 
 In addition to transcription initiation, it is important to review transcription 
elongation by RNA pol II in yeast because a number of histone PTMs are 
involved in this process (reviewed in [39]).  The C-terminal domain (CTD) of RNA 
pol II consists of a heptapeptide repeat with serines at positions 2 and 5, the 
phosphorylation of which is required for the transition from transcription initiation 
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to elongation [40].  Phosphorylation of serine 5 occurs at the 5´ end of the ORF, 
while phosphorylation of serine 2 occurs at a later phase of elongation [41].  The 
phosphorylated CTD creates a binding platform for factors at different stages of 
the elongation process [42].  An RNA pol II-associated factor (Paf1) associates 
with the serine 5-phosphorylated CTD [43-45] and participates in the recruitment 
of HMT Set1 (discussed later) [46-48].  Paf1 also recruits FACT [45], a histone 
chaperone complex, which destabilizes nucleosomes by removing H2A/H2B 
dimers out of the path of RNA pol II [49].  FACT also deposits H2A/H2B dimers to 
facilitate nucleosome re-assembly following transcription.  The factors that are 
recruited to the elongating RNA pol II illustrate that histone modification and 
chromatin remodeling are integral processes to transcription elongation. 
  
Methylation of Histone H3 Lysine 4 
 
 H3 K4 methylation has been implicated in transcriptional activation and 
elongation [39,50].  In S. cerevisiae, chromatin immunoprecipitation with specific 
antibodies against mono-, di-, and tri-methyl H3 K4 coupled to DNA microarrays 
showed the methylation status of H3 K4 across an average gene [10].  
Specifically, trimethylation of K4 was enriched at the 5´ end of transcribed genes, 
dimethylation in the middle, and monomethylation at the 3´ end of genes.  The 
same study showed that nucleosome occupancy is low at the promoters of active 
genes.  The same methods were used in higher eukaryotes to show that 
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trimethylation of H3 K4 was enriched at the 5´ end of actively transcribed genes, 
although patterns of dimethylation appear to differ [51-53].  Inactive genes were 
hypomethylated at H3 K4, demonstrating that H3 K4 methylation is correlated 
with transcriptional activity [51]. 
 The enzymes that methylate and demethylate H3 K4 have been identified, 
and deletion mutants of these enzymes solidify the relationship between H3 K4 
methylation and transcriptional activity.  In S. cerevisiae, H3 K4 is methylated by 
Set1, named for the presence of a SET domain, which is common to many HMTs 
[54].  Deletion of Set1 resulted in an expected loss of H3 K4 methylation as well 
as decreased transcription of 80% of yeast ORFs [55].  H3 K4 is demethylated by 
LSD1, a known member of a number of corepressor complexes [56].  Consistent 
with this, RNAi inhibition of LSD1 showed transcriptional de-repression in HeLa 
cells. 
 Like other histone PTMs, H3 K4 methylation mediates its effects by acting 
as a platform for the binding of effector proteins.  For example, BPTF, a member 
of the NURF ATP-dependent chromatin remodeling complex, preferentially binds 
trimethylated H3 K4, thereby recruiting NURF to nucleosomes enriched for H3 K4 
trimethylation [57,58].  Also, chromodomain-containing Chd1, a chromatin 
remodeling enzyme, binds methylated H3 K4 [59].  A component of SAGA and 
SLIK HAT complexes, Chd1 recruits these multisubunit coactivator complexes to 
sites of H3 K4 methylation.  These studies and others show that H3 K4 
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methylation promotes transcription by recruiting chromatin remodeling enzymes 
and HAT coactivator complexes to its target genes. 
 Finally, H3 K4 methylation was implicated in transcriptional elongation 
when it was shown that elongating RNA pol II interacts with a Complex of 
Proteins Associated with Set1 (COMPASS) [46-48].  COMPASS binds the CTD 
when the CTD is phosphorylated at serine 5, but not serine 2.  These studies 
show that COMPASS is associated with a specific form of the RNA pol II 
elongation complex, one that is present at the promoter region and 5´ end of the 
ORF, which corresponds with the localization of trimethyl H3 K4.  Some 
speculate that H3 K4 trimethylation by Set1 is required for the regulation of 
transcription initiation and promoter clearance, possibly through the recruitment 
of additional transcription factors [60].  The results also imply, as the authors 
suggest, that methylation may serve as a memory of those genes that have been 
recently transcribed, a mechanism that allows for the propagation of the active 
state through cell division.  
 
H2B K123 Ubiquitination is Required for H3 K4 and K79 Methylation in Yeast 
 
 Histone PTMs have been shown to facilitate or impede the placement of 
additional PTMs on the same or neighboring histones, in a phenomenon dubbed 
cross-talk [61].  One well-documented example of cross-talk is the relationship 
between H2B K123 ubiquitination and H3 K4 and K79 methylation in S. 
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cerevisiae [62-64].  Mutation of H2B lysine 123 to arginine abolishes H3 K4 and 
K79 methylation.  However, mutation of H3 lysine 4 to arginine does not affect 
H2B ubiquitination, indicating that H2B K123 ubiquitination is required for H3 K4 
and K79 methylation in a unidirectional pathway.  Only 5% of H2B is 
ubiquitinated, while a far higher percentage of H3 is methylated at K4, indicating 
that the effect of ubiquitination extends to neighboring nucleosomes.  The 
mechanism by which H2B ubiquitination signals for H3 K4 and K79 methylation is 
currently unknown (reviewed in [65]). 
  Monoubiquination of H2B is achieved through the actions of Rad6, an E2 
ubiquitin-conjugating enzyme, and Bre1, an E3 ligase [63,66].  Loss of either of 
these proteins or the interactions between them result in loss of ubiquitination 
and, subsequently, H3 K4 methylation.  The Paf1 complex is also required for 
H2B ubiquitination [47,67].  Paf1 may mediate H2B ubiquitination by facilitating 
an interaction between Rad6 and phosphorylated RNA pol II CTD, since mutation 
of the CTD or absence of serine 5 phosphorylation resulted in reduced levels of 
ubiquitination [68].  The interaction between Rad6 and the elongating form of 
RNA pol II suggests that H2B ubiquitination is involved in transcriptional 
elongation. 
 Removal of ubiquitin from H2B is achieved by deubiquitinating enzyme 
Ubp8, a member of the SAGA and SLIK HAT coactivator complexes [69,70].  
Ubp8 was shown to be associated with upstream regulatory elements of a 
SAGA/SLIK-dependent gene during activating conditions, while Rad6 was 
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present during non-activating conditions.  Also, deletion of Ubp8 results in 
decreased H3 K4 trimethylation at active genes and decreased expression of a 
SAGA/SLIK-dependent gene.  One possible theory for the role of Udp8 is that it 
recruits SAGA to sites of H2B ubiquitination, and deubiquitination is required for 
subsequent transcriptional activation [65].   
 One of the aims of this thesis is to determine whether the relationship 
between H3 K4 and K79 methylation and H2B K123 ubiquitination is conserved 




There are several ways in which chromatin structure may be altered [71].  
The first is by histone PTMs by pathways that have been discussed in detail.  
The second is by chromatin remodeling complexes, which disrupt histone-DNA 
interactions, allowing for transcription factor binding to DNA and subsequent 
gene activation [72].  The third way in which chromatin structure may be altered 
is by the replacement of major histones with histone variants.  
Incorporation of histone variants into the nucleosome has been implicated 
in a number of processes, including gene activation and silencing, chromosome 
segregation, X chromosome inactivation, and DNA repair [71].  I will focus on 
H2A.Z and H3.3, the incorporation of both of which is associated with specific 
transcriptional states.  In S. cerevisiae, the H2A.Z homologue, Htz1, localizes to 
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regions of euchromatin that are adjacent to heterochromatin, suggesting that 
Htz1 may act as a boundary against the propagation of heterochromatin [73].  
Accordingly, deletion of Htz1 resulted in the spread of Sir2 and Sir3 into 
euchromatic regions and reduced expression of associated genes.  Htz1 is also 
enriched at inactive promoters that are poised for activation [74-76].  Upon 
activation, H2A.Z is evicted from the nucleosome, enabling active transcription 
complexes to be assembled at the promoter [76,77].  However, in mammalian 
cells, H2A.Z appears to be associated with heterochromatin [78].  In developing 
mouse embryos, H2A.Z localizes to pericentric heterochromatin and interacts 
with a pericentric heterochromatin binding protein.  Also, H2A.Z may be required 
for binding of HP1 to chromatin, since depletion of H2A.Z disrupted HP1-
chromatin interactions [79].  These studies suggest that histone variant H2A.Z is 
involved in the maintenance of heterochromatin and euchromatin, although its 
exact role is organism-specific. 
While major histones are incorporated into a nucleosome during S phase, 
variant histones may be deposited during S phase or in a replication-independent 
manner.  In S. cerevisiae, the protein Swr1, a Swi2/Snf2-related chromatin 
remodeling ATPase, was shown to catalyze the exchange of H2A/H2B dimers for 
Htz1/H2B dimers [80-82].  Swr1 and Htz1 co-immunoprecipitated with Bdf1, a 
protein containing two bromodomains, which may be involved in targeting the 
complex to euchromatin [81].  These studies identify a chromatin remodeling 
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mechanism by which histone variants replace canonical histones outside of S 
phase. 
Like H2A.Z, deposition of histone variant H3.3 takes place outside of S 
phase [83].  In Drosophila, H3.3 differs from major H3 by only four amino acids; 
site-directed mutagenesis of these residues in major H3 allowed for some 
replication-independent deposition of major H3.  The four distinctive H3.3 amino 
acids may mediate its interaction with the histone chaperone HIRA, which is 
required for replication-independent nucleosome deposition of H3.3 [84]. H3.3 
deposition also depends on chromodomain protein Chd1, a chromatin 
remodeling enzyme that interacts with HIRA [85].  Like H2A.Z, replication-
independent deposition of H3.3 employs chromatin-remodeling enzymes to 
replace major H3 with an H3 variant within the nucleosome. 
The consequence of replacing major H3 with H3.3 is not completely 
understood, but appears to involve transcriptional activation.  Chromatin 
immunoprecipitation showed that H3.3 is found at the promoters of 
transcriptionally active genes [86].  Correspondingly, H3.3 is enriched for PTMs 
associated with transcriptional activity [87].  Also, H3.3 may prevent the spread of 
heterochromatin since it is incorporated at a demonstrated boundary element 
[88].  Some propose that deposition of H3.3 alleviates repression of major H3 
resulting from PTM-mediated silencing [83].  They suggest a mechanism by 
which transcriptional activation can be achieved through histone variant 
incorporation into the nucleosome.  
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Histone variants are present in a number of divergent organisms, including 
Trypanosoma brucei and other kinetoplastids.  The role of histone variants in 
these organisms is currently being investigated. 
 
Trypanosoma brucei and African Sleeping Sickness 
 
 Trypanosoma brucei is a flagellated protozoan parasite responsible for 
African Sleeping Sickness in humans and is one of the species responsible for 
Nagana in livestock.  The prevalence of these diseases in sub-Saharan Africa is 
due to the geographic distribution of Glossina sspp. (tsetse), the insect vector 
responsible for the transmission of trypanosomes.  The World Health 
Organization estimates that 70 million people live in areas where disease 
transmission could take place, and between 300,000 and 500,000 people are 
currently infected.  Livestock infections have contributed to widespread economic 
deprivation and also perpetuate the human infection by acting as reservoirs for 
the parasite.  African Sleeping Sickness presents with central nervous system 
symptoms, including confusion, poor motor and sensory system functioning, and 
sleep cycle disturbances; trypanosomiasis results in coma and death, if left 
untreated.  Current drug treatments, which are not specific for trypanosomes, are 
toxic and have limited efficacy, so new drugs and vaccines must be developed to 
specifically target the parasite.   
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Variant Surface Glycoproteins 
 
 T. brucei successfully combats mammalian host defenses to establish and 
maintain an infection.  Early observations showed that relapsing fever, which was 
characteristic of trypanosome infections, was concurrent with waves of 
parasitemia [89]. These authors and others speculated that, as an antibody 
response was mounted against each wave of parasites, some trypanosomes 
evade the host immune response by spontaneously switching their surface 
antigen, in a process known as antigenic variation.  The surviving cells then 
initiate a new wave of parasitemia.  
The dense coat comprised of surface antigen was first visualized by 
electron microscopy [90].  Purification and characterization of the surface coat 
antigen led to the identification of Variant Surface Glycoproteins (VSG), 
approximately 10 million identical copies of which are found on the plasma 
membrane [91].  Due to the dense packing of VSGs, only VSG epitopes are 
available to the host antibody, while invariant surface proteins are protected [92].  
It was recognized, then, that each wave of parasitemia in an infected patient was 
due to a different VSG expressed as the surface coat [93].  Recent sequencing 
and bioinformatic analysis of the T. brucei genome shows that there are 
approximately 1600 VSG genes and pseudogenes [94,95].  Sequencing of 
additional strains shows that >50% of a megabase chromosome can be 
comprised of VSG [96].   
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The T. brucei genome consists of 11 diploid megabase chromosomes (1-
5.2 Mb), an indeterminate number of intermediated chromosomes (200-700 kB), 
and approximately 100 minichromosomes (25-150 kB) [97,98].  Megabase 
chromosomes contain housekeeping genes and VSG ES, intermediate 
chromosomes also contain ES, and minichromosomes act as reservoirs for 
arrays of silent VSG.  Although not all of the VSG are intact, the repertoire is 
sufficient to maintain an infection for the lifespan of the host. 
 
Lifecycle Stages  
 
Trypanosomes are transmitted to mammalian hosts by tsetse.  Upon 
infection, the parasites differentiate into proliferating bloodstream forms (BF), 
which are characterized morphologically as long slender forms (Fig. 1.1, [99]) 
[100].  As parasitemia increases, trypanosomes differentiate to non-proliferating 
stumpy forms, which presumably prolongs the host’s survival by limiting parasite 
numbers.  Both long slender and short stumpy BF express VSG.  During a 
bloodmeal, tsetse injests the parasites, which differentiate to the proliferating 
procyclic forms (PF) in the insect midgut. PF express a small family of invariant 
proteins called procyclins to form a protective surface coat [101].  As the 
trypanosomes pass to the salivary glands, they differentiate through a 
proliferating epimastigote form to a non-dividing terminally differentiated and 
infective metacyclic form.  Metacyclic forms express a limited repertoire of VSGs  
Figure 1.1.  Trypanosoma brucei life cycle.  During a bloodmeal, the tsetse injests 
bloodstream form trypanosomes.  In the midgut, trypanosomes differentiate into 
procyclic forms, which express a small family of invariant surface proteins called 
procyclins.  Trypanosomes migrate to the salivary glands of the tsetse and 
differentiate into metacyclic forms, which express a limited repertoire of VSGs in 
preparation for infection in a mammalian host.  Following infection, parasites 
again differentiate into bloodstream forms.  Trypanosomes expressing VSGs or 
procyclins on their surface coat are shown in red and green, respectively.  
Reproduced from [9].       
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in preparation for their adaptation to the mammalian host [102]. Once the 
parasites have infected humans, they differentiate again into proliferating 
bloodstream forms. 
Differentiation from BF to PF is accompanied by a number of physiological 
changes that enable the trypanosome to adapt to its new environment [103].  
Lifecycle differentiation from BF to PF can be achieved in culture, so that these 
processes may be studied [104].  Upon differentiation to PF, trypanosomes no 
longer require a defense against a host antibody response, so the VSG coat is 
shed and all ES become transcriptionally inactive [101,105].  Cells that were in a 
non-proliferative state in the mammalian host, re-enter the cell cycle and begin to 
undergo DNA synthesis [106,107].  Metabolic changes are observed upon 
differentiation to PF [108], since BF survive primarily on its host’s glucose stores.  
Changes in the cellular architecture and morphology are also observed, including 
repositioning of the kinetoplast [109].  These adaptations require coordinated 




VSGs are expressed in BF from polycistronic transcription units known as 
Expression Sites (ES) that, importantly, are transcribed by RNA polymerase I 
(RNA pol I) [110].  There are approximately 20 ES in the genome of the T. brucei 
Lister 427 strain [111,112], each of which contain a single VSG. The remaining 
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hundreds of silent VSGs are found at non-transcribed telomeric loci and in 
transcriptionally silent subtelomeric arrays [94-96]. 
ES are located at the telomeres of some of the 11 diploid megabase 
chromosomes and variable numbers of smaller ‘intermediate’ chromosomes (Fig. 
1.2, [113]). Transcription of the ES is initiated at the ES promoter [114].  ES are 
comprised of a ~50 kb array of genes, termed Expression Site Associated Genes 
(ESAGs), terminating at the subtelomeric VSG [115-117].  Eleven families of 
ESAGs have been identified, some of which have been characterized in detail 
[94].  ESAG6 and ESAG7, for example, encode the two subunits of a 
heterodimeric transferrin receptor that localizes to the flagellar pocket [118,119]; 
sequence variation of ESAG6 and ESAG7 between ES led to the idea that ES 
switching optimizes transferrin uptake from the host serum [120], although this 
remains a controversial hypothesis [121].  However, despite their close physical 
association with the VSG, none of the ESAGs has yet been shown to be involved 
in regulating VSG expression.  In addition to the ESAGs, a number of repetitive 
DNA sequences are associated with the ES; these include 50 bp repeats 
upstream of the ES promoter, 70 bp repeats upstream of the VSG, and the 





Figure 1.2.   Architecture of the VSG Expression Site (ES).  ES are 50 kb polycistronic transcription units that terminate at 
the subtelomeric VSG.  Up to eleven families of Expression Site-Associated Genes (ESAG 1-11) are located in the ES.  
The ES is flanked by 50 bp repeats and telomeric repeats, and there are 70 bp repeats upstream of the VSG.  
Reproduced from [23].
50 bp repeats                                      Expression Site Associated Genes                           70 bp repeats  VSG
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Mechanisms of VSG Switching 
 
There are three major mechanisms by which VSG expression can switch 
[122].  The most common [123], gene conversion, occurs when the VSG in the 
active ES is replaced by another gene, and the original gene is not retained in the 
genome [124,125].  The new VSG can either be from a telomere (telomere 
conversion) or a chromosome-internal site (duplicative transposition).  The 
second mechanism is known as reciprocal recombination, and occurs when the 
active ES VSG is exchanged with a new telomeric VSG, and no genetic material 
is lost [126-128].  In situ switching, the third mechanism, occurs when 
transcription at the active ES is switched off and concurrently switched on at 
another ES [128]. The switching frequency for VSGs varies from 10-3–10-5 
switches/cell/generation [129].  The mechanisms that regulate VSG switching are 
far from understood and are discussed in some detail below. 
 
Chromatin Structure in Trypanosoma brucei 
 
Trypanosomes are highly divergent from other model organisms (Fig. 1.3, 
[130]), and chromatin structure has been shown to differ.  Unlike other 
organisms, condensed chromosomes are not visible during nuclear division in 
trypanosomes.  Chromatin from BF, PF, and rat liver were examined by electron 
microscopy at increasing ionic strength [131].  At high salt concentrations,  
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Figure 1.3.  Evolutionary tree.  An evolutionary tree shows the divergence of 
trypanosomes from other model organisms.  It also shows the divergence of 
other parasitic organisms, including Giardia lamblia, Toxoplasma gondii, and 
Plasmodium falciparum.  Reproduced from [130].  
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condensation was achieved in BF and, to a lesser extent, in PF, but trypanosome 
chromatin was not compacted to the same degree as rat liver chromatin.  
Comparison of PF and BF histones on a TAU gel demonstrated different band 
patterns.  Also, incubation of BF and PF chromatin with micrococcal nuclease 
showed different digestion patterns; PF chromatin was digested more readily 
than BF, suggesting that the DNA-histone interactions in PF are weaker than in 
BF.  Both BF and PF chromatin are more readily digested than rat liver 
chromatin.  The authors of this study suggest that there are structural differences 
between BF and PF chromatin, both of which have weaker DNA-histone 
interactions than other organisms.   
An additional study demonstrated that trypanosome chromatin is more 
accessible to T7 RNA polymerase than chromatin from other organisms [132]. 
The T7 polymerase is a single DNA-binding protein that can access the T7 
promoter without the help of any other protein factors [133,134].  When the T7 
system was introduced into the mouse germ line, only short promoter-proximal 
transcripts could be detected, indicating that the chromatin structure of higher 
eukaryotes provided minimal accessibility to T7 polymerase [133].  In contrast, 
T7 transcription in trypanosomes is very processive, producing transcripts ~3 kb 
from the transcription start site [132].  These studies confirm that trypanosome 
chromatin is in a more accessible confirmation than chromatin from other 
organisms. 
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Divergent Histone Sequences in Trypanosomes and Other Organisms 
 
 The above studies demonstrate that histones and chromatin structure are 
different in T. brucei compared to other model organisms, and histone sequences 
differ considerably (Fig. 3.28).  Comparison of the yeast N-terminal histone 
sequence to T. brucei and other divergent organisms, including Plasmodium 
falciparum and Giardia lamblia, demonstrate the sequence divergence (Fig. 1.4).  
Interestingly, G. lamblia and Entamoeba histolytica have N-terminal extensions of 
H3 and H4, respectively.  Some well-studied lysines are conserved among the 
divergent organisms, such as H3 K4 and H4 K12, K16, and K20.  The 
conservation of these lysines through millions of years of evolution suggests that 
they play important roles.  Leishmania major, Trypanosoma cruzi, and T. brucei 
histone sequences are well-conserved.  Therefore, studying PTMs in any one of 
these organisms will most likely reveal common principles in all of them. 
 Sequence alignments of the histone N-termini of these organisms 
demonstrate a few important points.  First, although histone sequences are highly 
conserved among most model organisms, they do differ among evolutionarily 
divergent organisms.  Therefore, PTMs cannot be divined simply by looking at 
sequence alignments, so it is necessary to perform an unbiased survey of 
histone PTMs from each of these organisms.  Also, commercially available 
antibodies are not specific for PTMs from divergent organisms, so, in order to 
study them, specific antibodies must be raised.  Second, conservation of amino  
Figure 1.4.  Sequence alignments of the N-termini of each core histone from
evolutionarily divergent organisms. Identical residues are shaded. The sequence 
ruler is numbered according to the S. cerevisiae sequence.  (A) H2A.  (B)  H2B.  
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acids and PTMs may demonstrate important sequences that are essential to all 
organisms, thereby illustrating the fundamental properties of chromatin biology.  
Third, functional studies of individual PTMs may uncover new pathways in which 
they are involved and new relationships between PTMs, revealing the full scope 
of chromatin biology.  Therefore, it is important to study histone PTMs in 
divergent organisms both for their own sake and to enrich our understanding of 
chromatin in more frequently studied model organisms. 
 
Transcription in Trypanosoma brucei 
 
 Transcription in trypanosomes differs from most other organisms in a few 
important ways [135-137].  First, genes are arranged in polycistronic transcription 
units.  Genes are grouped randomly, and not as functional units.  Second, there 
is apparently unregulated RNA pol II transcription of protein-coding genes.  No 
RNA pol II promoter has been identified upstream of protein-coding genes.  It is 
hypothesized that RNA pol II “touches down” on a chromosome at sites that are 
relatively free of ORFs and initiates transcription bi-directionally; genes on either 
side of this site are arranged in the same orientation [138,139].  Since 
transcription is apparently unregulated, mRNA transcripts have sequences within 
the 3’ UTR that direct its degradation so that levels of transcripts may be 
controlled [140]. 
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The third way in which transcription is different is that trypanosome 
mRNAs undergo trans-splicing.  RNA pol II transcribes spliced leader RNA 
(SLRNA), which is capped at the 5´ end [141-143].  SLRNA is trans-spliced to the 
5´ end of each ORF.  Trans-splicing at the 5´ end of the subsequent ORF 
releases the 3´ end of the transcript, which then undergoes polyadenylation 
[144,145].  Trans-splicing uncouples the processes of transcription and mRNA 
capping.  In other organisms, mRNA is capped at the 5´ end co-transcriptionally 
by capping machinery that associates with the elongating RNA pol II [42], which 
necessitates that RNA pol II transcribes protein-coding genes.  
Trans-splicing alleviates the need for RNA pol II to transcribe all mRNA, 
so, in T. brucei, RNA pol I transcribes VSGs and procyclin [110].  This may allow 
for independent regulation of these genes.  In keeping with the uncoupling of 
transcription and mRNA capping, the serine-rich trypanosome RNA pol II CTD 
lacks heptapeptide repeats [146,147]; therefore, it is not clear whether the CTD 
will act as a binding platform for elongation and RNA processing factors as it 
does in other organisms [42]. 
 The apparently unregulated transcription of most protein-coding genes is 
consistent with the observation that trypanosome chromatin is in an open 
conformation.  For this reason, it seems likely that most trypanosome chromatin 
is euchromatin, with the possible exception of subtelomeric regions where VSG 
are located.   
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Regulation of Monoallelic VSG Expression 
 
The mechanism regulating whether an ES is transcriptionally silent or 
active has not been elucidated.  Some theories are discussed below. 
Transcription Initiation.  Initiation of transcription does not appear to be 
a regulated process in trypanosomes.  The absence of identifiable homologues of 
common transcription factors and the organization of genes into polycistronic 
units suggest that transcription itself may not be highly controlled [148]; 
trypanosomes appear to preferentially utilize other means of regulating mRNA 
abundance, especially by RNA processing and degradation [135-137].  
It is not surprising, then, that ES promoters are nearly identical in 
sequence, and the deletion of sequences surrounding them does not affect the 
transcription levels of ES-associated genes [149].  Also, replacement of the ES 
promoter with an rRNA promoter allows for effective silencing and activation in 
inactive and active ES, respectively, but not after differentiation to PF [150].  
These studies demonstrate that the ES promoter and surrounding regions are not 
critical for ES activation.  Finally, transcription is initiated at many, if not all, ES, 
all of which argues against a strong role for regulation at the level of transcription 
initiation [111].   
 Transcription Elongation and RNA Processing.  Although transcription 
is initiated at a number of ‘silent’ ES, transcription is rapidly attenuated such that 
only a single VSG is transcribed, suggesting that ES are regulated at the level of 
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transcription elongation [111].  Using RT-PCR, transcripts were analyzed using 
four sets of primers that annealed at different sites throughout the ES.  PCR 
products were then sequenced to determine the number of ES represented.  
Immediately downstream of the promoter (1-200 bp), transcripts from nearly all 
ES are present; 1000-1200 bp from the promoter, heterogeneity of transcripts 
was reduced, but multiple ES were still represented; at the VSG, only transcripts 
from the active ES were identified.  Transcripts were then fractionated by 
oligo(dT) chromatography into polyA+ and polyA- groups, which were analyzed 
by the same methods.  The authors showed that only transcripts from active ES 
have a polyA tail, demonstrating that preferential RNA processing contributes to 
the dominance of active ES transcripts.   
 Expression Site Body.  Monoallelic expression of VSGs may also be 
mediated by a specialized structure, the expression site body (ESB), which is not 
present in the PF nucleus [151].  An antibody was developed against a subunit of 
RNA pol I, and immunofluorescence was used to show a transcriptionally active 
RNA pol I-containing structure in the nucleus distinct from the nucleolus.  The 
active expression site was tagged and shown to co-localize with the RNA-pol I 
containing body, but inactive ES do not co-localize.  Also, the ESB is still present 
following DNA digestion by DNAse I, demonstrating that the ESB is a physical 
structure and not simply an accumulation of RNA pol I on an active ES.   
Chromatin Structure. A number of studies suggest that chromatin 
structure at the ES may influence its transcriptional activity. The active ES 
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displays greater sensitivity to digestion with DNase I and single-strand-specific 
endonucleases than inactive ESs, which suggested a more open chromatin 
conformation at the active ES [152,153]. Micrococcal nuclease digestion at the 
promoter region of an active and inactive ES gave similar digestion patterns, 
suggesting that there are no differences in the chromatin conformation at the ES 
promoter [149]. Therefore, any differences in chromatin structure between active 
and inactive ES would be found closer to the 3´ end of the ES, where the VSG is 
located.  
Chromatin structure was further implicated in transcriptional silencing 
when it was shown that transcription was repressed from both ES and rRNA 
promoters following their insertion into an inactive ES [154]. Upon differentiation 
to PF, the rRNA promoter was de-repressed, while the ES promoter remained 
repressed, suggesting that there are two separate mechanisms controlling ES 
silencing in BF and PF.  The authors concluded that silencing in BF was due to a 
position effect caused by restrictive chromatin structure, while silencing in PF 
may be, at least partially, due to lack of BF ES promoter-specific factors.  Other 
studies demonstrate that transcription levels decreased as the promoters were 
placed closer to a telomere [155].  These studies suggest that ES silencing in BF 
is due to a repressive chromatin conformation, but that ES silencing requires 
mechanisms in addition to telomere-mediated silencing (see next section). 
A similar study was performed using a T7 polymerase and promoter, 
which allowed for the accessibility of chromatin at ES to be examined directly, in 
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the absence of protein factor interactions that might confound results from the 
RNA pol I studies [156].  A T7 RNA polymerase-driven luciferase reporter 
cassette was integrated in an inactive ES as well as in non-transcribed, non-ES 
sites, including the rRNA spacer region and upstream of the chromosome-
internal VSG118 gene.  The T7 promoter was active in all locations in BF, 
indicating that these sites provided the minimum chromatin accessibility required 
for transcription by T7 polymerase.  Therefore, repression of RNA pol I-mediated 
transcription might be due to the absence of protein factors required for 
transcription elongation. 
These studies sparked an interest in the effects of chromatin remodeling 
and histone modifying enzymes on ES activity.  In a screen for genes involved in 
ES silencing, a Swi2/Snf2-related chromatin remodeling enzyme, TbISWI, was 
identified in trypanosomes [157]. In both BF and PF, RNAi knockdown of TbISWI 
led to de-repression of a fluorescent marker placed downstream of an inactive 
ES promoter.  However, no VSG transcripts from inactive ES were observed, 
indicating that TbISWI may be involved in silencing at the ES promoter, but not at 
the subtelomeric VSG.  Deletion or knockdown of trypanosome histone modifying 
enzymes have similarly been tested for their role in ES silencing.  The results of 
these studies are discussed later. 
Telomeric Silencing.  Insertion of two VSG genes into a single active ES 
resulted in the stable expression of two VSGs on the trypanosome surface coat 
[158].  Double expressors had similar growth rates and infectivity in rats as wild-
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type cells.  When compared to a study mentioned earlier in which double 
expressors were engineered by inducing rapid switching between ES [159], the 
results imply that regulation is based not on the expression of a single VSG, but 
on the expression of only one ES subtelomeric region.   
To investigate telomeric silencing in T. brucei, one group seeded de novo 
telomeres with an expression cassette 2 kb and 5 kb downstream of an rRNA 
promoter [160].  Expression from the rRNA promoter was low when the telomere 
was 2 kb from the promoter and increased as the distance between the telomere 
and the promoter increased, demonstrating that RNA pol I transcription is 
repressed by telomeres.  However, seeding of de novo telomeres 2 kb and 5 kb 
downstream of a silent VSG both resulted in strong repression, indicating that 
another mechanism is involved in silencing at BF ES.  This was confirmed upon 
differentiation to PF, when VSG expression was de-repressed at 5 kb from the 
telomere, but not at 2 kb.   
Additional evidence that telomeric silencing was not the sole mechanism 
governing VSG silencing was provided by the same group [161].  The construct 
used to seed de novo telomeres was introduced into telomerase deficient cells 
with a unique restriction site upstream of the telomeric repeats.  Cleavage with a 
conditional endonuclease resulted in loss of the telomere, which, in turn, resulted 
in de-repression of reporter constructs at non-ES telomeres, but not at ES 
telomeres.  The authors provide direct evidence for the existence of telomeric 
silencing at non-ES loci, but they show that telomeres are not an absolute 
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requirement for ES silencing.  However, they cannot exclude the possibility that 
telomere binding proteins may recruit silencing proteins or induce DNA or 
chromatin modifications; telomere loss would result in loss of binding proteins, 
but would not reverse existing modifications.  Therefore, restrictive chromatin 
structure formed as a result of these modifications may still be a factor in ES 
silencing.  To conclude with more certainty that silencing is not nucleated at the 
telomere, the authors could cleave an active site telomere and induce an in situ 
switch.  They could then determine if a formerly expressed VSG is effectively 
silenced in the absence of a telomere. 
Although telomeres have a limited role in VSG silencing, there is some 
evidence to suggest that they influence VSG switching.  Deletion of telomerase 
resulted in the progressive shortening of telomeres [162].  The problem of 
critically short telomeres at the active ES was solved by recombination with a 
telomere from a silent ES, resulting in the replacement of the active site VSG with 
the VSG associated with the donor telomere (telomere conversion).  In wild-type 
cells, the active ES is subject to breakage at the telomere, possibly due to 
destabilization of telomere structure that allows RNA pol I to transcribe to the 3´ 
end of the ES [163,164].  The authors propose that telomere breakage at the 
active site is the impetus for VSG switching, which occurs at random at a 
frequency of 10-3–10-5 switches/cell/generation [129]. 
Conclusion.  There is some evidence to suggest that chromatin structure 
plays a role in the regulation of VSG expression.  Although the chromatin 
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structure in trypanosomes has been shown to be in a relatively open 
conformation, perhaps heterochromatin forms at the 3’ end of ES, thus restricting 
transcription of all but one VSG.  Whether heterochromatin forms at the ES 
telomere, as it does in other organisms, is debatable. Once thought to mediate 
ES silencing, telomeres were shown to not be absolute requirements for 
silencing, but may play a role in VSG switching.  Characterization of chromatin 
structure and the factors that influence it, the most important of which are histone 
modifications, is necessary for understanding the mechanisms regulating VSG 
expression.  
 
Trypanosome Chromatin Biology 
 
T. brucei genome.  Sequencing of the T. brucei genome identified 
several putative histone-modifying enzymes: 5 HAT, 7 HDAC (including 3 SIR2-
related proteins), 2 DOT1-like HMT, 3 SET-domain-containing HMT, and 4 
arginine HMT [148].  The genome sequencing also revealed that genes encoding 
for major histones are present in tandem arrays, which presumably allows for 
increased expression of these genes.  There are 13 copies of H2A on 
chromosome 7, 14 copies of H2B on chromosome 10, 7 copies of H3 on 
chromosome 1, and 10 copies of H4 on chromosome 5.  Trypanosome histone 
sequences, which are very divergent compared to other organisms, are 
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discussed in Chapter 3.  Finally, one copy each of genes encoding variants of the 
four major histones were identified. 
 PTMs on trypanosome histones.  Two studies have been published 
identifying PTMs on T. brucei PF histones and T. cruzi H4 [165,166].  The 
findings are discussed in Chapter 3. 
 Histone modifying enzymes.  A number of studies have been published 
recently identifying histone modifying enzymes in trypanosomes, including DOT1-
like HMTs, HATs, and HDACs.  Two DOT1-like HMTs, DOT1A and DOT1B, are 
responsible for the dimethylation and trimethylation, respectively, of T. brucei H3 
K76, the S. cerevisiae H3 K79 homologue [166].  Dimethylation of H3 K76 was 
shown to be cell cycle-regulated; K76 dimethylation was only detectable during 
mitosis, while trimethylation was present throughout the cell cycle.  Disruption of 
DOT1A (lethal) and DOT1B (non-essential) impaired life cycle differentiation and 
progression through the cell cycle.  Specifically, DOT1A knockdown cells were 
able to undergo mitosis before completing DNA replication, resulting in the 
presence of apparently haploid cells. The authors propose that DOT1A and 
DOT1B play a regulatory role at the mitotic checkpoint through methylation of H3 
K76.   
Deletion of yeast DOT1 disrupts telomeric silencing [167].  Similarly, 
recent experiments show that deletion of DOT1B results in de-repression at 
inactive ES (L. Figueiredo, unpublished data).  Specific antibodies were used to 
show that two VSGs are expressed simultaneously in mutant cells in the absence 
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of drug selection.  Therefore, deletion of DOT1B appears to disrupt telomeric 
silencing, a role that is homologous to its yeast counterpart, and may be a 
regulator of ES silencing. 
 Of the 5 putative HATs in T. brucei, HAT3, which is non-essential, has 
been shown to function in vivo as an H4 K4 HAT [168].  An HDAC was not 
identified for acetylated H4 K4.  Exposure of cells to cycloheximide, a protein 
synthesis inhibitor, led to an immediate loss of unmodified H4 K4.  The authors 
suggest that newly synthesized histones are unmodified at H4 K4 in the cytosol 
and are acetylated inside the nucleus, possibly irreversibly.  The biological 
outcome of H4 K4 acetylation is currently unclear, especially since it seems not 
to be essential.  
 Two studies have provided an overview of the 7 putative HDACs in T. 
brucei [169,170].  Fluorescence microscopy studies of 3 T. brucei SIR2-related 
proteins, TbSIR2RP-1-3, show that TbSIR2RP-1 localizes to the nucleus, while 
TbSIR2RP-2 and TbSIR2RP-3 are found in the mitochondria, suggesting that 
perhaps only TbSIR2RP-1 will have a role in transcriptional silencing [170].  Two 
studies showed that TbSIR2RP-1 does not affect ES silencing [170,171].  
However, deletion of TbSIR2RP-1 results in modest de-repression of reporter 
expression at non-ES subtelomeric loci, suggesting that TbSIR2RP-1 plays a role 
in establishing telomeric silencing [170].  Finally, TbSIR2RP-1 has in vitro 
deacetylase and ADP-ribosyltransferase activity against histones, but its in vivo 
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target has yet to be identified [172].  These studies are discussed in more detail 
in Chapter 4. 
Of the remaining 4 HDACs, DAC1-4, two were encoded by essential 
genes (DAC1 and DAC3) and two were not (DAC2 and DAC4) [169].  
Interestingly, Δdac4 cells demonstrate cell cycle defects, which were illustrated 
by growth delays and an accumulation of cells in late G2 phase.  However, 
neither the Δdac2 nor Δdac4 cells demonstrated changes in VSG expression or 
an inability to undergo lifecycle differentiation. 
An overview of the histone modifying enzymes and corresponding PTMs 
shows that they affect several biological processes in trypanosomes, including 
progression through the cell cycle, life cycle differentiation, and gene expression.  
De-repression of inactive ES following disruption of DOT1B provides preliminary 
evidence for a role for histone PTMs in the maintenance of ES silencing.   
Histone variants.  Two studies have been published characterizing 
histone variants in T. brucei [173,174].  One study identified H2A and H2B 
variants [174], H2AZ and H2BV, which are discussed in more detail in Chapter 5.  
Briefly, both variants are encoded by essential genes.  The authors show, by co-
immunoprecipitation, that H2AZ and H2BV heterodimerize in the same 
nucleosome.  By chromatin immunoprecipitation, it was shown that H2AZ and 
H2BV were enriched at repetitive DNA.  H2AZ and H2BV were not detected at 
inactive ES, although their presence at active ES could not be determined.  
Finally, it was shown that H2AZ does not co-localize with sites of BrUTP 
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incorporation, indicating that the histone variants are not found at sites of active 
transcription. 
 H3 variant H3V is encoded by a non-essential gene [173].  
Immunofluorescence shows that the localization of H3V shifts throughout the cell 
cycle and co-localizes with the mitotic spindle and telomeres.  Chromatin 
immunoprecipitation confirmed that H3V was enriched at telomeric DNA, 
although subtelomeric VSG transcription was unaffected by the loss of H3V.  The 
authors conclude that H3V may have a telomere-specific function and suggest a 
role for the variant in ES silencing, which may have been masked if another 




 Packaging of DNA into nucleosomes acts to repress transcription by RNA 
pol II.  In yeast and other organisms, elongating RNA pol II recruits chromatin 
remodeling and histone modifying enzymes that presumably enable it to 
overcome this transcriptional repression.  In trypanosomes, although DNA-
histone interactions are weaker than in higher eukaryotes, it seems likely that 
heterochomatin assembly at the 3´ end of inactive ES inhibits RNA pol I 
processivity.  It is hypothesized that the ESB possesses elongation factors that 
enable RNA pol I to overcome nucleosomal repression, and it is likely that some 
of these factors will be chromatin remodeling and histone modifying enzymes. 
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In trypanosomes, we are far from understanding the processes of 
heterochromatin assembly and RNA elongation, both of which are informed by 
histone PTMs in other organisms.  As a first step toward studying chromatin 
structure in trypanosomes, I performed a detailed survey, using Edman 
degradation and mass spectrometry (MS), to identify as many as possible of the 
PTMs present on histones H2A, H2B, H3, and H4, which I purified from the BF of 
T. brucei strain Lister 427. Although histones are highly conserved in most 
organisms, the amino acid sequences of T. brucei histones are very different, 
and we cannot infer what modifications will be present, based on sequence 
alignments (Fig. 3.28).  Similar studies have been performed in T. cruzi and T. 
brucei PF.  Structural differences between BF and PF chromatin have already 
been identified [131]; I compared our findings from the two lifecycle stages and 
attempt to identify stage-specific histone PTMs.  Also, I compared our findings to 
marks found in yeast and other organisms to make predictions about the role of 
trypanosome PTMs. 
 Next, I began to characterize a putative histone deacetylase, TbSIR2RP-1.  
TbSIR2RP-1 was chosen for the role that yeast SIR2 plays in heterochromatin 
formation.  I investigated the target of TbSIR2RP-1 and find that, unlike its yeast 
counterpart, TbSIR2RP-1 is not an H4 deacetylase.  I suggest that TbSIR2RP-1 
may be an H2A deacetylase, but further work will be required to justify this claim. 
 Finally, I began to look at marks particularly associated with transcriptional 
elongation in other organisms.  Based on our MS data and a sequence 
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comparison between yeast and trypanosome H3, I infer that H3 lysine 4 is 
trimethylated. Commercial antibodies that recognize modifications in other 
organisms cannot be expected to specifically cross-react with trypanosome 
PTMs, and the most likely ones do not (unpublished data).  Therefore, a specific 
antibody was raised against trimethyl H3 K4 to begin characterizing this mark.   
I also generated a hypothesis regarding the relationship between PTMs on 
different histones based on sequence comparisons.  I found that histone variant 
H2Bv lysine 129 is homologous to S. cerevisiae H2B lysine 123. However, unlike 
yeast, I showed that trypansome H2Bv K129 ubiquitination is not required for 
downstream H3 K4 and K76 methylation. Interestingly, I found that H3 K4 and 
K76 methylation is enriched in nucleosomes containing H2Bv.  I propose that 
H2Bv deposition in the nucleosome is sufficient to act as a trigger for 
downstream methylation of H3 K4 and K76. 
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Chapter 2.  Materials and Methods 
 
Amplification of BF 221wt Trypanosomes in Rats 
 
Approximately 5x105 BF 221wt were used to infect 3 CD-1 female swiss 
white mice.  The infection took place for 3 days after which point the mice were 
assessed for parasitemia.  Whole blood from the animals that maintained the 
infection was used to infect 3-10 Sprague Dawley male rats (1-2x107 tryps were 
needed to infect each rat).  Following a 3 day infection period, rats were 
exsanguinated from the aorta, and the blood was centrifuged at 1,000g for 10 
min at 0 ºC in a Sorvall RT6000B centrifuge.  Three layers were observed 
following centrifugation, and the top layer (plasma) was discarded.  
Trypanosomes were resuspended in BBSG (0.050 M Bicine;  0.077 M glucose;  
0.050 M NaCl;  0.005 M KCl;  pH 8.0) and centrifuged at 1,000g for 10 min at 0 
ºC in a Sorvall RT6000B centrifuge.  The top layer was discarded, and the bottom 
layer was resuspended in BBSG.   
Prior to this stage, DEAE-52 beads were poured to a final volume of 75 ml 
and washed with 150-200 ml BBSG.  The column was washed with cold BBSG 
immediately before application of the cells.  Trypanosomes were added to the 
column under reduced pressure until the column almost ran dry.  One column 
volume (75 ml) of BBSG was added to the column, and the trypanosomes were 
collected.  This protocol yields on the order of 1010-1011 cells. 
  41 
 
Purification of Histones from BF 221wt cells 
 
For purification of histones, 1x1010 BF 221wt cells were centrifuged at 
1,800g for 10 min at 4 ºC in Sorvall SS-34 rotor.  Cell pellet was washed with 10 
ml Trypanosome Dilution Buffer (0.005 M KCl, 0.080 M NaCl, 0.001 M 
MgSO4.7H2O, 0.020 M Na2HPO4, 0.002 M NaH2PO4.2H2O, 0.020 M glucose).  
Cells were resuspended in freshly made 20 ml 8% Polyvinyl pyrrolidone-40 + 
0.05% octyl glucoside and immediately processed with pre-cooled Polytron (PTA 
head 10, setting 6) with six 1 minute bursts at 4 ºC [175].  Samples were checked 
under microscope to ensure that cells were lysed before centrifuging at 16,000g 
for 5 min at 4 ºC in Sorvall SS-34 rotor.  The pellet was washed in 10 ml Buffer A 
(10 mM Tris, pH 8.0;  75 mM NaCl;  0.05% octyl glucoside).  The pellet was 
resuspended in 10 ml Buffer B (10 mM Tris, pH 8.0;  2 M NaCl;  1% octyl 
glucoside).  Octyl glucoside can be substituted with NP-40 for a better yield of 
histones, but NP-40 detergent contamination interfered with MS analysis in the 
final sample.  Nuclei were lysed with a dounce homogenizer (50 strokes, which 
was probably excessive) and centrifuged at 16,000g for 20 min at 4 ºC in Sorvall 
SS-34 rotor.  The supernatant was collected and divided into 0.9 ml aliquots.  For 
acid extraction, 0.1 ml 4 M H2SO4 was added to each aliquot and rotated 
overnight at 4 ºC.  Samples were centrifuged at 16,000g for 10 min at 4 ºC in a 
microcentrifuge.  The supernatant was collected and neutralized by adding 1 M 
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Tris, pH 9.0.  The sample was dialyzed overnight against Concanavalin A 
Equilibration Buffer (20 mM Tris, pH 7.4;  0.5 M NaCl) at 4 ºC.  All of the solutions 
used up to this point were treated with 1 mM DTT, 50 mM sodium butyrate, 0.5 
mg/ml TLCK, 0.174 mg/ml PMSF, and a protease inhibitor cocktail (Sigma). 
The sample was concentrated in a 15 ml Vivaspin concentrator by 
centrifugation at 2,000g for 3 hours at 4 ºC in a Sorvall RT6000B centrifuge.  To 
remove remaining VSG, which was otherwise the main contaminant in the 
purified histone preparation, the sample was applied to a 1 ml Concanavalin A 
column (Sigma) at 4 ºC.  The column was washed with 20 ml Wash Buffer (1 M 
NaCl;  5 mM MgCl2;  5 mM MnCl2;  5 mM CaCl2) and 2 ml Equilibration Buffer.  
The sample was applied to column, followed by 5 ml equilibration buffer.  Flow 
through was collected immediately after sample was added to column.  Flow 
through was frozen in liquid Nitrogen and stored overnight at –70 ºC prior to 
lyophilization. 
The sample was fractionated by RP-HPLC on a C8 column using an 
acetonitrile gradient (0 to 60%) in 0.1% trifluoroacetic acid.  Fractions were 
collected every minute for approximately 70 min, although later it was shown that 
histones eluted between 50 and 65 min.  Protein content was monitored by 
absorbance at 214 nm.  Fractions were lyophilized and resuspended in 50 µl 
ddH2O.  The composition of each fraction was determined by SDS-PAGE and 
MALDI of the intact proteins. 
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Analysis of Histones by Edman Degradation and Mass Spectrometry 
 
Edman degradation and mass spectrometry experiments were conducted 
by Joseph Fernandez and Haiteng Deng in the Proteomics Resource Center at 
The Rockefeller University.  Edman was performed using a Procise 494-HT with 
a PTH C18 HPLC column (Applied Biosystems).  Modified PTH standards (acetyl 
or methyl lysines) were made by reacting free amino acids (Sigma) with PITC to 
create PTC-amino acids.  These were then converted to PTH-amino acids by 
incubation with 25% trifluoroacetic acid.   
Histones were digested with endoproteinases Glu-C, trypsin, or Asp-N, 
according to the manufacturer’s instructions (Roche).  Some histone preparations 
were also modified with propionic anhydride prior to trypsin digestion, to block 
lysines from cleavage.  Histones were dissolved in 15-30 µl 1.0 M Tris, pH 8.0, 
and an equal volume of 1% propionic anhydride in acetonitrile (Aldrich)[176].  
The reaction was incubated 30-120 min (longer incubation times resulted in non-
specific modification at serines or threonines), dried, and digested with trypsin.  
Some digests were fractionated by HPLC in order to obtain information about 
minor species.  Peptides were isolated on a Vydac C18 column (1.0x150 mm) 
using a Helwett-Packard/Agilent 1100 HPLC system.   
Digests were first analyzed by MALDI-TOF, which was conducted using a 
DE-STR mass spectrometer operating in the delayed extraction and reflector 
modes (Applied Biosystems).  Samples were then analyzed by ESI-LC-MS/MS 
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connected to a PE Sciex Q-STAR (Quadropole-Time of Flight mass analyzer).  
Nanoflow, an electrospray ionization source, was performed using a 75 mm ID 
C18 column. 
 
Creating a ΔTbsir2rp-1 Cell Line 
 
In a BF 221wt background, the Tbsir2rp-1 single knockout was created by 
transfection of 10 µg pMH166 fragment (created by PvuII/HindIII digest) in 
1.5x107 cells and selection in HMI-9 media + 5.0 µg/ml hygromycin.  The 
Tbsir2rp-1 double knockout was created by transfection of 10 µg pMH167 
fragment (created by AlwNI/ApaLI digest) in 3.0x107 Tbsir2rp-1 single knockout 
cells and selection in HMI-9 media + 1.5 µg/ml neomycin.  pMH166 and pMH167 
were provided by M. Hoek [171].  Cell lines were verified by Southern blot. 
 
Triton-Acetic-Acid-Urea (TAU) Gel Electrophoresis  
 
Purified histones from BF 221wt and ΔTbsir2rp-1 cells were dried and 
resuspended in 5 µl freshly prepared loading buffer (0.36 g/ml Urea;  0.02% 
pyronin Y;  5% acetic acid;  25 mg/ml protamine sulfate).  Samples were loaded 
on 15% or 20% polyacrylamide (60% acrylamide:  0.4% bisacrylamide), 6 M 
Urea, 0.74% Triton X-100, 5% acetic acid gel and electrophoresed at 300 V in 
5% acetic acid.  TAU gels allow for the separation of histones based on their size 
  45 
and charge, which enables us to visualize different modified forms of these 
proteins [177].  Histones were visualized by silver staining. 
 
Purification of Histone H3 Lysine 4 Trimethyl and Unmethylated Antibodies 
 
Polyclonal antibodies were raised by immunizing rabbits (Sigma) with 
KLH-conjugated peptide RTKme0ETARTC (H3K4me0) or RTKme3ETARTC 
(H3K4me3).  The anti-H3K4me3 antibody was purified by first depleting the 
antiserum from rabbit 14,995 bleeds #1-3 on Sulfolink coupling gel (Pierce) linked 
to peptide VSGAQKme3EGLRFC (H3K76me3).  Each 1 ml of H3K4me3 
antiserum was incubated on an H3K76me3-conjugated column for 30 min at 4 
ºC.  Flowthrough and column washes were collected and concentrated in 
Vivaspin concentrators.  Following elution of the bound material from the 
H3K76me3 column, the depleted antiserum was incubated on the column a 
second time.  Flowthrough and column washes were collected.  Twice depleted 
H3K4me3 antiserum was affinity purified on an H3K4me3-conjugated column as 
described [178].  H3K4me0 antisera from rabbit 14,993 bleed #1 was affinity 
purified on an H3K4me0-conjugated column.  
The following peptides (10 ng/ml) were used to test antibody specificity: 
RTKme0ETARTC (H3K4me0), RTKme3ETARTC (H3K4me3), 
VSGAQKme0EGLRFC (H3K76me0), and VSGAQKme3EGLRFC (H3K76me3).  
Antibodies were incubated with peptide for 1 hr at RT prior to incubation of the 
Western blot, which contained 5 lanes of cell lysate from 2.0x106 PF 427wt cells. 
  46 
Fluorescence Microscopy  
 
Both BF 221wt and PF 427wt cells were stained with anti-H3K4me0 and 
H3K4me3 antibodies.  Approximately 5.0x106 cells were collected by 
centrifugation at 1,800g for 10 min.  The cell pellet was resuspended in 1 ml 
medium and fixed in 2% formaldehyde for 5 min at RT.  Cells were collected by 
centrifugation at 800g for 3 min and washed twice in PBS for 5 min with rotation.  
Cells were resuspended in 1 ml PBS, and 100 µl (5.0x105 cells) were dropped on 
silanized coverslips.  Cells were allowed to adhere to the coverslips for 20 min.  
Excess liquid was aspirated, and the coverslips were washed with PBS.  Cells 
were permeabilized in 0.1% NP-40 (0.2% for BF cells) for 5 min at RT and were 
then washed twice with PBS.  Cells were blocked twice with PBG for 10 min at 
RT with shaking, then incubated with 250 µl anti-H3K4me0 (diluted 1:100 for PF 
and 1:50 for BF) or anti-H3K4me3 (dil 1:2000 for PF and 1:750 for BF) antibodies 
diluted in PBG for 1 hr at RT with shaking.  Cells were washed 3x in PBS for 5 
min with shaking and once in PBG for 5 min.  Cells were incubated with 50 µl 
Alexa anti-rabbit secondary antibody (diluted 1:200) for 1 hr at RT with shaking.  
Coverslips were kept covered from this point forward to protect them from light.  
Cells were incubated in 0.5 mg/ml DAPI diluted in PBS for 10 min at RT with 
shaking, then washed 3x with PBS for 10 min with shaking.  Coverslips were 
mounted on slides with embedding media (20 mg p-phenylene diamene 
dissolved in 20 ml PBS diluted in glycerol).  For BF cells, trypanosome dilution 
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buffer was substituted for PBS.  Cells were examined using DeltaVision 
deconvolution microscopy (Applied Precision). 
 
H2Bv-FLAG cell lines 
 
Cell lines were derived from the single marker (sm) cell line, which 
constitutively expresses T7 polymerase and the tet repressor, allowing for 
inducible expression of ectopic genes that are downstream of the T7 promoter 
[179].  Plasmid pJEL69, which is used to introduce an inducible, ectopic copy of 
H2Bv-FLAG, was made by PCR amplifying the H2Bv ORF to include the FLAG 
epitope (DYKDDDDK) at the N-terminus (J. Lowell, unpublished data).  pJEL69 
was linearized with NotI and transfected in the single marker cell line.  Selection 
took place in HMI-9 with 2.5 µg/ml phleomycin.  The endogenous copies of H2Bv 
were replaced with puromycin and hygromycin drug resistance markers using 
deletion plasmids pJEL74 and pJEL75, respectively, to create BFJEL18 cells 
[174].  pJEL plasmids were provided by J. Lowell. 
 Plasmids used to introduce mutations in H2Bv-FLAG were derived from 
pJEL69.  Lysine 129 (AAA) was mutated to alanine (GCA) or arginine (AGA) 
using the QuikChange Site Directed Mutagenesis kit (Strategene).  The 
H2BvΔCTD mutation was made by PCR amplifying H2Bv 1-127 with a premature 
stop codon from pJEL69 and using it to replace the wildtype copy of H2Bv in the 
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same plasmid.  FLAG-tagged H2Bv mutants were used to replace endogenous 
H2Bv alleles in single marker cells as described above. 
 A cell line (BFJEL8) containing an inducible, ectopic copy of H2B-FLAG 
was also used [174]. 
 
Purification of H2Bv for MS and Western 
 
Histones were purified from BFJEL18 as described above.  In addition to 
protease inhibitors, solutions were treated with 10 mM iodoacetamide.  Following 
acid extraction and dialysis in TBS, the crude histone preparation was incubated 
on anti-FLAG M2 affinity gel (Sigma) with rotation for 2 hr at 4 ºC.  Bound 
material was washed three times with TBS and eluted by boiling the gel in 2x 
SDS loading buffer for 3 min.  The eluate was analyzed by Coomassie stain.  
Eight gel slices were cut from the gel ranging from ~17 to 35 kDa and analyzed 
by tandem MS.   
Eluate from 2.0x108 cells was also analyzed by Western blot with an anti-
ubiquitin antibody (P4D1, Santa Cruz Biotechnology).  Immunoprecipitated H2Bv-
FLAG was evaluated alongside 100 ng ubiquitin (Sigma) and cell lysate from 
2.0x106 BFJEL18 cells.  The blot was incubated in anti-ubiquitin antibody (diluted 
1:100) ON at 4 ºC. 
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Preparation of mononucleosomes and co-immunoprecipitation 
 
Mononucleosomes were prepared from cell lines containing the following 
inducible fusion proteins:  H2B-FLAG, H2Bv-FLAG, H2Bv K129A-FLAG, and 
H2Bv K129R-FLAG [174].  Approximately 1.5x108 cells were collected by 
centrifugation at 1,800g for 10 min.  Cells were then washed in trypanosome 
dilution buffer and resuspended in 1 ml permeabilization buffer (100 mM KCl; 10 
mM Tris, pH 8.0; 25 mM EDTA).  Digitonin was added to a final concentration of 
40 µM and incubated at RT for 5 min.  Permeabilized cells were collected by 
centrifugation at 800g for 3 min.  To remove EDTA, cells were washed 3x with 1 
ml cold isotonic buffer (100 mM KCl; 10 mM Tris, pH 8.0;  10 mM CaCl2;  5% 
glycerol).  The cell pellet was resuspended in 0.5 ml isotonic buffer and incubated 
with 2 U micrococcal nuclease for 5 min at 25 ºC in a water bath.  The reaction 
was stopped with EDTA (10 mM final concentration).  To solubilize chromatin, 
NaCl (200 mM final concentration) and NP-40 (0.05% final concentration) were 
added, and the reaction was incubated on ice for 5 min.  Soluble 
mononucleosomes were collected in the supernatant following centrifugation at 
16,000g for 10 min.  1.5% mononucleosomes were set aside for Western blot 
analysis.  Isotonic buffer was treated with 0.5 mg/ml TLCK, 0.174 mg/ml PMSF, 
and a protease inhibitor cocktail (Sigma). 
For the co-immunoprecipitation, mononucleosomes were incubated on 
anti-FLAG M2 affinity gel (Sigma) with rotation for 2 hours at 4 ºC.  Bound 
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material was washed once with isotonic buffer with 200 mM NaCl for 10 min with 
rotation.  Bound material was then washed twice with isotonic buffer for 10 min 
with rotation.  Immunoprecipitate was eluted by boiling the gel in 2x SDS loading 
buffer for 3 min.  Approximately 33% of the H2Bv immunoprecipitate and 11% of 
the H2B immunoprecipitate were analyzed by Western blot.  The 3:1 ratio of 
H2Bv to H2B IP resulted in approximately equal loading of total H3, which was 
demonstrated with a general anti-H3 antibody (Abcam 1791). 
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Chapter 3.   Purification of Histones from T. brucei Bloodstream Forms and 




As described in chapter 1, previous studies of T. brucei ES have 
suggested a role for chromatin structure in the regulation of VSG expression.  
Whether chromatin is in a permissive or restrictive state for access by 
transcription machinery is influenced in part by which histone modifications are 
present.  To begin to understand the relationship between chromatin structure 
and gene expression in trypanosomes, I proposed to first identify the histone 
modifications present in BF cells.  Typically, histones are highly conserved 
proteins, so modifications can be identified by homology using well-studied model 
systems such as yeast as a guide.  However, trypanosome histones diverge 
significantly from this consensus, so I expected to uncover unique modifications 
that have not been previously described, although some of the marks that are 
identified will be conserved in other organisms as well.  I did not expect that 
trypanosome histones would contain many modifications because sequencing of 
the T. brucei genome showed that there are few putative histone modifying 
enzymes [148], and only a few of these have been shown to function in their 
predicted roles [169,172].   
 
  52 
Some histone modifications in PF trypanosomes have been identified 
previously by our lab [165].  Here, a more comprehensive survey of histone 
PTMs is performed in BF trypanosomes.  Since VSG expression is limited to 
bloodstream and metacyclic forms, our preliminary survey may uncover lifecycle-
specific candidate modifications. 
To begin this analysis, I developed a purification strategy for histones from 
BF trypanosomes.  The strategy used to purify PF histones was not successful in 
BF because it required the purification of nuclei.  BF nuclei are more fragile than 
in PF and lysed during purification [175].  Therefore, I avoided the purification of 
nuclei, but maintained the same basic outline as the PF protocol [165].  The 
protocol includes the following steps:  cell lysis and collection of the insoluble 
material, including the nuclei and plasma membrane, lysis of the nuclei, collection 
of the soluble nuclear contents, extraction of basic proteins with acid, removal of 
contaminating VSG using a Concanavalin A column, and separation of histones 
by HPLC.   
Analysis of purified histones was performed using Edman degradation and 
mass spectrometry.  Edman degradation is a quantitative method that can be 
used to uncover modifications in the N-terminus by comparison to amino acid 
standards with known elution patterns.  Quantitation is possible by calculating the 
area under the curve representing the modified amino acid as a fraction of the 
total amino acid.  Edman degradation is limited by the inability to sequence 
proteins that are blocked at the N-terminus by modification of the primary amine, 
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the requirement for a significant amount of starting material, the ability to provide 
accurate sequence information for only the first ~20 amino acids, and the lack of 
sensitivity for the identification of minor modifications.  Mass spectrometric (MS) 
methods have been developed more recently to identify histone modifications 
and complement the information provided by Edman degradation.  To be 
analyzed by MS, histones must first be digested with an endopeptidase, and 
resulting peptides are separated according to their mass by MALDI-TOF.  
Sequence information for individual peptides is provided by MS/MS, which 
fragments amide bonds to produce a series of peaks with differences in mass 
that correspond to the mass of each amino acid and its potential modification.  
The drawbacks of MS are that the protein of interest must be amenable to 
digestion by the available endoproteases and the peptides produced may be too 
large or small or may have other characteristics that prevent them from 
registering on a MALDI-TOF spectrum.  Also, tandem MS (MS/MS) data may be 
incomplete, which complicates the assignment of modifications to a specific 
lysine, especially when multiple lysines are present on a single peptide.  Finally, 
the presence of multiple species of a modified peptide on a single spectrum 
further complicates the assignment of peaks to an individual species.  With these 
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Results 
 
Purification of Histones from Bloodstream-Form Trypanosomes 
 
To develop a protocol to purify histones from BF trypanosomes, I took 
advantage of their two essential properties:  they are found in the nucleus and 
are basic proteins. Histones were previously purified from PF by isolating nuclei, 
then using acid extraction and RP-HPLC purification [165,175].  This method was 
attempted in BF trypanosomes, but the yield was extremely low (<1%) (Fig. 3.1). 
The greatest loss of material occurred during nuclei isolation, which I attributed to 
the increased fragility of the BF nucleus. Consequently, the protocol I developed 
did not involve the purification of nuclei as an intermediate step.  The cells were 
lysed with a Polytron and the nuclei and plasma membrane were separated from 
the cytosolic fraction by centrifugation, resulting in a crude nuclear preparation.  
Several methods were employed for disruption of the plasma membrane, 
including osmotic lysis and lysis with RIPA buffer (137 mM NaCl;  20 mM Tris-Cl, 
pH 7.4;  10% (v/v) glycerol;  1% (v/v) Triton X-100;  0.5% (w/v) sodium 
deoxycholate;  0.1% (w/v) SDS;  2.0 mM EDTA;  1.0 mM PMSF;  20 mM 
leupeptin) containing 1% NP-40, but mechanical disruption using a Polytron 
appeared to be the most effective.   
Figure 3.1.  Histones from purified nuclei.  SDS-PAGE of acid-extracted histones 
following purification of nuclei by Rout and Field protocol (178).  Lanes 1-3 contain 
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Following cell lysis and isolation of the crude nuclear fraction by 
centrifugation, the nuclei were washed in a low-salt buffer (10 mM Tris, pH 8.0;  
75 mM NaCl;  0.05% NP-40) and resuspended in a high-salt buffer (10 mM Tris, 
pH 8.0;  2 M NaCl;  1% NP-40).  The nuclei were mechanically disrupted using a 
dounce homogenizer, and the soluble fraction containing histones was separated 
from the insoluble material, including the nuclear and plasma membranes by 
centrifugation.  Initially, histones were retained in the insoluble fraction, until the 
salt concentration in the high-salt buffer was increased from 0.4 M to 2.0 M NaCl 
(Fig. 3.2).  Another method of liberating histones from the insoluble fraction 
involved permeabilizing the nuclei with digitonin and treating the chromatin with 
micrococcal nuclease.  However, because increasing the salt concentration 
effectively released most of the histones into the supernatant, it was unnecessary 
to treat the nuclei with micrococcal nuclease. 
The supernatant was then treated with 0.4 M H2SO4, resulting in the 
solubilization of basic proteins, which were separated from insoluble proteins by 
centrifugation.  At this stage, histones were heavily contaminated with VSG, 
which was not efficiently removed in later stages of our purification strategy, so 
VSG was depleted by passing the sample over a ConA column.  To remove 
detergent and acid from the basic proteins before introducing the sample onto the 
column, the acid was neutralized with 1 M Tris, pH 9.0, and the sample was 
dialysed against ConA equilibration buffer (20 mM Tris, pH 7.4;  0.5 M NaCl).   
Figure 3.2.  Optimization of salt concentration.  SDS PAGE following histone 
isolation at salt concentrations ranging from 0.4-2.0 M NaCl.  Histones are 
maximally released from the nuclear pellet into the supernatant at 2.0 M NaCl. 
S - supernatant, P - pellet 
 S       P       S       P        S       P       S       P        S        P
[NaCl]    400 mM      800 mM    1200 mM   1600 mM      2000 mM
histones
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The yield at this stage was approximately 30% of our starting material in 
the crude nuclear pellet (Fig. 3.3). 
In order to separate histones among themselves and from other remaining 
basic proteins, the sample was fractionated by RP-HPLC in an acetonitrile 
gradient (performed in collaboration with S. Hake, Fig. 3.4), lyophilized, and 
redissolved in H2O. Analysis of HPLC fractions by Coomassie staining of 
polyacrylamide gels and by MALDI-TOF MS demonstrated the high purity of the 
final histone preparations (Fig. 3.5). Preliminary experimental analysis of all 
HPLC fractions showed that histones were only present in fractions 45 through 
62.  Histones H2A and H3 co-eluted on the HPLC (MW 14.2 and 14.7 kDa, 
respectively), which I unsuccessfully attempted to resolve in several ways.  First, 
HPLC fractions were collected every half minute instead of every minute, but H2A 
and H3 still eluted in the same fractions.  Secondly, H2A- and H3-containing 
fractions were separated on an AU gel, individual bands were excised, and 
histones were eluted from the gel in 5% acetic acid.  Disappointingly, this 
produced a yield of less than 10%.  Finally, I considered running these fractions 
on a second HPLC column, but had insufficient material to do so.  Although it 
would be convenient to have H2A and H3 in separate fractions, I did not attempt 
to separate them further because the presence of both histones in a single 
sample did not interfere with MS or Edman analysis. Only the H2A N-terminus 
was susceptible to Edman sequencing, because the H3 N-terminal Serine (S1) 
was blocked, as previously shown in T. brucei PF [165]. 
Figure 3.3.  Final yield of crude histone purification.  (A)  Flow diagram of 
purification protocol.  (B)  SDS-PAGE of sample from each step of the purification 
process.  Lanes are as follows:  (1) Starting material, (2) supernatant following 
initial centrifugation, (3) soluble fraction following cell lysis, (4) low salt buffer 
wash, (5) crude nuclei resuspended in high salt buffer, (6) soluble fraction 
following mechanical disruption of nuclei, (7) insoluble fraction following 
mechanical disruption of nuclei, (8) proteins solubilized in sulfuric acid, (9) ConA 
flow through.






1 Collected tryps from rats
Lyse cells with Polytron      2 supernatant
Wash cells with low salt buffer      3 supernatant
5 Resuspend pellet in high salt buffer    4 supernatant
Lyse nuclei with douncer
6 Acid extraction    7 pellet
8 ConA column     pellet
9 HPLC
Figure 3.4.  HPLC Elution Profile of BF 221 Histones.  Crude histone preparation was fractionated by RP-HPLC.  
Absorbance 214 nm.  H2B and H4 were eluted individually, but H2A and H3 eluted in overlapping fractions.  






Figure 3.5.  SDS-PAGE of HPLC-purified Histones.  One fraction was collected
each minute.  One-tenth of each HPLC fraction was loaded on an SDS-PAGE 
and stained with Coomassie.  Fractions 47-50 contain H2A and H3, fractions 
51-56 contain H4, and fractions 56-62 contain H2B.  Histones were identified by 
MALDI-TOF MS.  Only fractions containing histones were loaded.  Additional
HPLC fractions did not contain histones.
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When NP-40 was used in the protocol, our final yield of histones was 
approximately 30%. These samples were analyzed by Edman degradation, but 
NP-40 contamination of the purified histones prevented us from acquiring MS  
data. Substituting octyl glucoside for NP-40 prevented detergent contamination of 
the final samples, but resulted in a lower yield (~10%). 
 
Edman degradation and MS analysis 
 
A combination of MS techniques, including MALDI-TOF and ESI-MS/MS, 
and Edman degradation, was used to analyze T. brucei histones for PTMs.  
Edman degradation provided quantitative data for PTMs on the N-terminal 20–30 
amino acids.  For MS, histones were first digested with trypsin. Histones contain 
many arginine and lysine residues, resulting in excessive fragmentation by 
trypsin. In some experiments, therefore, histones were modified with propionic 
anhydride to prevent trypsin cleavage at lysine residues by propionylation (+56 
Da) of unmodified (K) and monomethylated (Kme1) lysines, and the N-terminus. 
Dimethylated (Kme2), trimethylated (Kme3) and acetylated (Kac) lysines were 
not propionylated, but are also not cleaved by trypsin. Histone H3 was also 
digested with endoproteinases Asp-N and Glu-C, and H4 was digested with Glu-
C.   
MALDI-TOF analysis provided the molecular mass of the digested 
peptides. Mass shifts of 14, 28, and 42 Da may represent peptides with a 
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monomethyl, dimethyl, and trimethyl or acetyl group, respectively. The peptides 
were then sequenced by tandem MS to assign PTMs to their parent residue. 
Acetyl (42.0105 Da) and trimethyl (42.0468 Da) groups are difficult to distinguish 
by tandem MS. I relied on data generated by Edman degradation to help us 
assign mass shifts of 42 Da. Acetylated lysines also produce a characteristic 
immonium ion at m/z 126, and trimethylated lysines have a characteristic ion at 




Analysis of the first 22 amino acids of H2A by Edman degradation 
demonstrated that 60% of A1 is monomethylated, and ~1% of K4 is acetylated 
(Fig. 3.6A, Table 3).  The monomethylation of alanine may be a novel histone 
modification and was also found in T. brucei PF histones and T. cruzi [165,181]. 
Tandem MS data were acquired for trypsin-digested H2A (Fig. 3.7A). 
Peptides that were analyzed are shown in red. Trypsin digestion produced 
several spectra representing modified C-terminal peptides, demonstrating that 
K115, K119, K120, K122, K125, and K128 can be acetylated (Fig. 3.8-12, Table 
1).  In PF, all but one of these acetylated lysines (K122) were identified.  I 
assigned these modifications as acetylation rather than trimethylation, because 
studies of PF histones showed that H2A exists in multiple acetylation states 








Figure 3.6.  Edman degradation identifies PTMs at the N-termini of H2A and H2B. 
The PTMs were verified by comparison to known standards. (A) The PTH HPLC 
trace for cleavage cycle 1 of H2A shows that ~60% of A1 is N-methylated (NMA). 
The trace for cycle 4 shows that ~1% of K4 is acetylated. (B) The trace for cycle 1 
of H2B shows that ~60% of A1 is N-methylated. The trace for cycle 4 shows that 
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Figure 3.7.  T. brucei histone sequences with regions for which tandem MS data were 
acquired following endoproteinase digestion highlighted in red. (A) H2A trypsin digest. 





TABLE 1. Posttranslational modifications on histones H2A, H2B, and H3 



























a Histones, which in some cases were modified with propionic anhydride, were 
digested with trypsin. 
b Tryptic peptides were sequenced by tandem MS, and peptides that have 
covalent modifications are listed here. 
 
 
G G V M P S L N Kac A L A K
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Figure 3.8.  Histone H2A lysine 115 is acetylated.  H2A tryptic peptide 107-119 (GGVMPSLNKALAK) was sequenced by 
tandem MS.  Ion pair y4-y5 demonstrates that K115 is acetylated.  m/z 664.42+; theoretical MW = 1327.7 Da; 





















































































G G V M P S L N Kac A L A Kac Kac Q K
                      y12 y11 y10 y9  y8           y7  y6  y5   y4          y3           y2   y1  
                b3   b4                b7                      b10
K119acK120ac
K115ac
Figure 3.9.  Histone H2A lysines 115, 119, and 120 are acetylated.  H2A tryptic peptide 107-122 
(GGVMPSLNKALAKKQK) was sequenced by tandem MS.  Ion pairs y2-y3, y3-y4, and y7-y8 show that K120, K119, and 



































































































A L A Kac Kac Q Kac S G K
y9  y8  y7          y6           y5    y4           y3   y2    y1




Figure 3.10.  Histone H2A lysines 119, 120, and 122 are acetylated.  H2A tryptic peptide 116-125 (ALAKKQKSGK) was 
sequenced by tandem MS.  Ion pairs y6-y7 and b3-b4 demonstrate that K119 is acetylated; y5-y6 demonstrates that K120 
is acetylated;  y3-y4 and b6-b7 demonstrate that K122 is acetylated.  The presence of the acetyl lysine immonium ion 
(m/z 126) supports the claim that the +42 Da shift for each lysine is due to acetylation, not trimethylation.  m/z 592.92+;  


















































































S G Kac H A Kac A T P S V
y10                                           y5   y4  y3   y2   y1
                     b3    b4                 b6  b7  b8   b9  b10
Figure 3.11.  Histone H2A lysines 125 and 128 are acetylated.  H2A tryptic peptide 123-133 (SGKHAKATPSV) was 
sequenced by tandem MS.  Sequencing of this peptide is incomplete, but the b series (b3, b4, b6) support the assignment 

































































H A Kac A T P S V
y7  y6                 y4   y3  y2   y1
      b2         b3   b4  b5          b7
Figure 3.12.  Histone H2A lysine 128 is acetylated.  H2A tryptic peptide 126-133 (HAKATPSV) was sequenced by tandem 
MS.  Ion pairs b2-b3 and and y4-y6 demonstrate that K128 is acetylated.  m/z 426.82+; theoretical MW = 852.4 Da; 
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supported this assignment. Multiple modifications of the H2A C-terminus have 
not been reported in other organisms.  No peptides corresponding to the N-
terminus were found after trypsin digest, most likely because there are five 
lysines and one arginine present that would result in excessive fragmentation of 
this sequence.  
Next, H2A was modified with propionic anhydride prior to trypsin digest 
(hereafter referred to as PA-trypsin digest) to acquire information about the N-
terminus (Fig. 3.7B).  MALDI-TOF analysis of the PA-trypsin-digested H2A 
demonstrated that the N-terminus is present in three modified states (Fig. 3.13A).  
Tandem MS sequencing of these species demonstrated that A1 can be 
monomethylated, acetylated, or unmodified (Fig. 3.13B-D, Table 1).  The y series 
of these spectra are identical.  The mass shift from modified A1 can be observed 
by subtracting y16 from the MH+ value of the spectra.  Also, the b series are 
shifted by the mass of the modification (see the b6 ion in all three spectra).  
Premature cleavage of peptide 1-17 resulted in peptide 3-17, which was then 
sequenced, adding several additional peaks representing the y series of peptide 
3-17 to these spectra.  Peptides representing the C-terminus (H2A 107-133) 
were also found, but were too large to interpret. 
In other organisms, the C-termini of H2A and H2B are ubiquitinated 
[182,183]. Alignment of the H2A C-terminus (Fig. 3.28B) suggests that T. brucei 
H2A K122 might be the homologue of the ubiquitinated H2A K119 in other 
organisms. We therefore performed a directed search for ubiquitinated H2A  












M + 42 Da
M + 56 Da
M + 70 Da
Figure 3.13.  Histone H2A alanine 1 may be unmodified, acetylated, or monomethylated.  Tryptic peptide 1-17 
(ATPKQAVKKASKGGSSR) of propionylated H2A was subjected to MALDI-TOF analysis and sequencing by tandem MS.  
(A)  MALDI-TOF shows that peptide 1-17 is present in three modification states.  M is the molecular mass ion of peptide 
1-17 with all lysines propionylated (1924 Da).  Tandem MS sequencing of peaks labeled M + 42 Da, M + 56 Da, and 
M + 70 Da species indicate that H2A A1 may be acetylated, propionylated (meaning it is unmodified), or both 
propionylated and monomethylated, respectively.  (B)  MS/MS shows that H2A A1 is acetylated (m/z 984.12+).  
Theoretical MW = 1967.0 Da; measured MW = 1967.2 Da.  (C)  MS/MS shows that H2A A1 is unmodified (m/z 991.12+).  
Theoretical MW = 1981.0 Da; measured MW = 1981.2 Da.  (D)  MS/MS shows that H2A A1 is monomethylated 
(m/z 998.12+).  Theoretical MW = 1995.0 Da; measured MW = 1995.2 Da.  These assignments were made by looking at 
the b ions, which are all shifted relative to the unmodified species.  Also, the difference between the MH+ of the spectrum 




























































































        b2    b3    b4     b5   b6      b7   b8    
y16  y15          y13   y12  y11   y10   y9    y8    y7    y6    y5     y4      y3    y2    y1
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        b2    b3    b4     b5   b6      b7   b8    b9   
y16  y15          y13   y12  y11   y10   y9    y8    y7    y6    y5     y4      y3    y2    y1
Ame1 T P K Q A V K K A S K G G S S R1 17
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K122. MS can identify sites of ubiquitination by looking for a GG dinucleotide 
linkage (114 Da) to lysine, which results from tryptic cleavage of covalently linked 
ubiquitin (-RLRGG) [184]. The tandem MS spectrum of a peptide with m/z 
1029.263+ displayed partial y-series (y1-y6, y8, y15) and b-series (b3, b12, b22-
24) ions, demonstrating that the spectrum represents propionylated H2A peptide 
107–133 (Fig. 3.14). The molecular weight of this species and the y- and b-ions 
indicate that K115 and K128 are propionylated, and, of the remaining 4 lysines 





Edman degradation of the first 25 amino acids of H2B demonstrated that 
60% of A1 is monomethylated, and ~1% of K4 is acetylated (Fig. 3.6B, Table 3). 
Both H2A and H2B begin with the sequence ATPK, and both are modified at A1 
and K4 to the same degree. PA-trypsin digestion of H2B provided MS/MS data 
for the lysine-rich N-terminus (Fig. 3.7C). Quadropole-quadropole-TOF (QqTOF) 
analysis of the H2B digest showed that N-terminal peptide 1-11 can be present in 
three modification states (Fig. 3.15A).  Tandem MS sequencing of these peaks 
showed that A1 can be unmodified, mono-, or di-methylated (Fig. 3.15B-D, Table 
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Figure 3.14.  The C-terminus of histone H2A is ubiquitinated.  Propionylated H2A was digested with trypsin, producing 
peptide 107-133 (GGVMPSLNKALAKKQKSGKHAKATPSV).  Sequencing of this peptide by tandem MS shows that three 
lysines are acetylated and one is ubiquitinated (modified lysines shown in red).  m/z 1029.262+  Theoretical MW = 2057.5 Da.




































M + 28 Da
M + 56 Da
M + 70 Da
Figure 3.15.  Histone H2B alanine A1 can be unmodified, mono-, or dimethylated. Propionylated H2B was digested with 
trypsin, producing peptide 1-11 (ATPKSTPAKTR).  (A) QqTOF data shows that peptide 1-11 is present in three 
modification states.  M is the molecular mass ion of the peptide when all of the lysines are propionylated.  Sequencing by 
tandem MS confirmed that these peaks correspond to H2B peptide 1-11.  The isotope pattern demonstrates that these 
peaks represent the +2 species.  (B) MS/MS shows that the peak labeled M + 56 Da represents unmodified A1, meaning 
that it is propionylated (m/z 663.42+).  Theoretical MW = 1325.7 Da; measured MW = 1325.8 Da.  (C)  MS/MS shows that the 
peak labeled M + 70 Da represents monomethylated and propionylated A1 (m/z 670.42+).  Theoretical MW = 1339.7 Da; 
measured MW = 1339.8 Da.  (D)  MS/MS shows that the peak labeled M + 28 Da represents dimethylated A1 (m/z 649.42+).  
Theoretical MW = 1325.7 Da; measured MW = 1325.8 Da.  These assignments can be observed from the b ions, which are 
all shifted relative to the unmodified species.  The mass difference between the MH+ of the spectrum and y10 also provides 
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Ame2 T P K S T P A K T R
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can be observed by subtracting y10 from the MH+ value or from the shift in the b 
series (see the b2 ion in all three spectra).   
One spectrum was obtained representing two species of peptide 12–18, 
which showed that K12 or K16 is acetylated (Fig. 3.16, Table 1). Ions b2-b3 and 
y4-y6 are present for both species, which allows us to estimate the abundance of 
the modified species based on the intensity of these peaks.  I estimate that 
acetylated K12 represents approximately 30% of the modified species, and 
acetylated K16 is ~70%.  The PTMs were designated as acetylated lysines 
because the Kac immonium ion was present at m/z 126. These marks are 




Multiple attempts were made to acquire information on the modification state of 
H3. Many of the peptides produced by the PA-trypsin digest of H3 were 
sequenced by tandem MS (Fig. 3.7D). QqTOF analysis of the H3 PA-trypsin 
digest showed multiple modification states for the lysine-rich peptide 9–36 (Fig. 
3.17A). Sequencing by tandem MS showed that all 8 lysines are propionylated in 
the species represented as M + 448 Da. Tandem MS of the three remaining 
peaks showed that they represent modified species of peptide 9–36, but 
modifications could not be assigned to specific lysines. The presence of these 
peaks suggests that several lysines at the H3 N-terminus can be modified. 
Mass (m/z)
K E A K K T R
y6   y5  y4    y3  y2   y1 
 b1   b2  b3          b5  








Figure 3.16.  Fig. 4. Histone H2B lysines 12 and 16 are acetylated. H2B was propionylated and digested by trypsin. 
Peptide 12-18 (KEAKKTR) was sequenced by tandem MS. A single MS spectrum contains two modified species, 
demonstrating that either K12 (b2”-b3” and y3”-y6”) or K16 (b1'-b3' and y3'-y6') are acetylated.  

















































































M + 238 Da
M + 448 Da

















Figure 3.17.  The N-terminus of histone H3 is present in multiple modification states. Quadrupole-quadrupole-TOF data 
were acquired for H3 digested with endoproteinases trypsin and Asp-N. M is the molecular ion mass of each peptide. 
(A) Propionylated H3 digested with trypsin produces peptide 9-36 (TKKTITSKKSKKASKGSDAASGVKTAQR), which was 
observed as [MH4]4+(m/z 723.9). Sequencing by tandem MS of the peptide labeled M + 448 Da shows that this is the 
species for which all 8 lysines are propionylated. Magnification of peak M + 448 Da (inset) shows the isotope pattern of 
this peptide, which enabled us to determine that this is a +4 species. Partial sequencing by tandem MS of the remaining 




3.17B. Asp-N-digested H3 produces peptide 1-25 (SRTKETARTKKTITSKKSKKASKGS), which was observed at m/z 548.3 
for [MH5]5+.  Sequencing by tandem MS confirms that the peak labeled M is unmodified peptide 1-25.  Partial sequencing 
by tandem MS of the three modified species M + 14 Da, M + 28 Da, and M + 42 Da confirms that they correspond to 











M + 28 Da
M
M + 14 Da
M + 42 Da
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 A spectrum corresponding to the N-terminus, peptide 1–8, showed that 
S1 can be acetylated (Fig. 3.18, Table 1).  Peptide 1-8 was the result of an 
incomplete trypsin digest at R2, possibly due to the proximity of the cleavage site 
to the N-terminus.  Peptide 3-8 was also sequenced by MS/MS, showing that K4 
was propionylated (data not shown).  However, peptide 3-8 with a methylated K4 
was not observed.  QqTOF of the H3 PA-trypsin digest also showed that peptide 
70-80 can be present in four modification states (Fig. 3.19A).  Tandem MS 
sequencing of these peaks showed that K76 can be unmodified, mono-, di-, or tri-
methylated (Fig. 3.19B-E, Table 1).  The spectra representing di- and tri-methyl 
K76 are incomplete, but a shift in the y series at y5 and the b series at b7 
represents the mass shift from modified K76 (see y6-y9 and b9 for dimethyl K76, 
and y7-y9 and b7-b10 for trimethyl K76).  This modification has also been 
characterized in PF [165]. 
Although the N-terminus of H3 was blocked to analysis by Edman 
degradation, I attempted to acquire Edman degradation data by separating the 
peptides from the PA-trypsin digest by HPLC and sequencing peptide 9–36. A 
weak profile was obtained, but no PTMs were detectable.  Interpretation of the 
Edman degradation data was further complicated by the simultaneous 
sequencing of an H2A peptide. 
Tandem MS sequencing of trypsin-digested H3 uncovered two 
modifications at the N-terminus — K23ac and K32me3 (Table 1). K23 was shown 

































































Sac R T K E T A R
       b2   b3  b4   b5   b6  b7
      y6   y5          y3  y2   y1 
Figure 3.18.  Histone H3 serine 1 is acetylated.  Propionylated H3 was digested with trypsin, producing peptide 1-8 
(SRTKETAR).  Tandem MS sequencing demonstrates the modification - all b ions are shifted relative to the unmodified 




































Figure 3.19.  Histone H3 lysine K76 may be mono-, di-, or trimethylated. Propionylated H3 was digested with trypsin, 
producing peptide 70-80 (EVSGAQKEGLR).  (A) Qq-TOF data shows that peptide 70-80 is present in 4 possible 
modification states.  M is the molecular mass of the unmodified peptide.  The isotope pattern demonstrates that these 
peaks represent the +2 species.  Sequencing by tandem MS confirms that these peaks correspond to H3 peptide 70-80.  
(B)  MS/MS data of the peak labeled M + 28 Da shows that H3 K76 is dimethylated (m/z 601.42+).  
Theoretical MW = 1201.6 Da; measured MW = 1201.8 Da. (C)  MS/MS data of the peak labeled M + 42 Da shows that 
H3 K76 is trimethylated (m/z 608.42+).  Theoretical MW = 1215.6 Da; measured MW = 1215.8 Da.  (D)  MS/MS data of the 
peak labeled M + 56 Da shows that H3 K76 can be unmodified (propionylated) (m/z 615.42+).  Theoretical MW = 1229.6 Da; 
measured MW = 1229.8 Da.(E)  MS/MS data of the peak labeled M + 70 Da shows that H3 K76 can be monomethylated 
and propionylated (m/z 622.42+).  Theoretical MW = 1243.6 Da; measured MW = 1243.8 Da.  These assignments can be 







M + 28 Da
M + 42 Da
M + 56 Da
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A S Kac G S D A A S G V K
       b2           b3   b4          b6  
 y11 y10         y9   y8   y7    y6  y5   y4   y3          y1  
Figure 3.20.  Histone H3 lysine 23 is acetylated.  H3 was digested with trypsin, producing peptide 21-32 (ASKGSDAASGVK).  
Acetylation is demonstrated by ion pairs b2-b3 and y9-y10 and the presence of the acetyl lysine immonium ion (m/z 126).  
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spectrum representing modified K32 is incomplete.  The presence of the y4 and 
y7-y12 ions demonstrates that there is a mass shift of +42 Da on the GVK 
sequence, which I assign to K32.  K32 was shown to be methylated by the 
presence of MH+-59 ion (Fig. 3.21).  The density of basic amino acids at the H3 
N-terminus prevented other modified lysines from being discovered following 
trypsinization.  
Finally, I attempted MS analysis of Asp-N- and Glu-C-digested H3. QqTOF 
analysis of Asp-N-digested H3 confirmed that multiple modification-states exist 
for N-terminal peptide 1–25 (Fig. 3.17B). Some MS/MS data were acquired for 
modified peptide 1-25, but were uninterpretable, primarily due to the number of 
lysines present and the observation of these peptides as +5 species.  Glu-C-
digested H3 was expected to produce peptides 1-5 and 6-47, but neither were 
visible by MS.  I concluded our study of H3 with the knowledge that PTMs were 




Edman degradation of the first 22 amino acids showed that, unlike H2A 
and H2B, the H4 N-terminus has numerous PTMs (Fig. 3.22, Table 3). K2, K5, 
K10, and K14, are acetylated in less than 10% of H4. K4ac is an abundant mark 
that is found in 73% of H4. Both K17 and K18 can be mono-, di-, or tri-methylated 
and 60% of A1 is monomethylated. 
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Figure 3.21.  Histone H3 lysine 32 is trimethylated.  H3 was digested with trypsin, producing peptide 24-36 
(GSDAASGVKTAQR).  Modification of K32 is demonstrated by ion pair y4-y7.  The assignment of trimethylation was 




Figure 3.22.  Edman degradation identifies PTMs at the H4 N-terminus. The 
PTMs were verified by comparison to known standards. (A) The PTH HPLC trace 
for cleavage cycle 1 of H4 shows that ~60% of A1 is N-methylated (NMA). 
(B) The trace for cycles 17 and 18 shows that K17 and K18 are mono-, di-, and 
tri-methylated. (C) The trace for cycles 2, 4, 5, and 10 show that 2% of K2, 73% 
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I examined H4 in more detail by MS, to confirm the PTMs observed by 
Edman degradation as well as to determine whether less abundant PTMs were 
present. H4 Glu-C, trypsin-, and PA-trypsin-digested peptides were fractionated 
by HPLC, and individual fractions were analysed by MALDI-TOF.  Fractionating 
the digest uncovered a number of peaks that were not visible prior to 
fractionation, presumably because multiple modifications of a single peptide 
divided the signal or stronger peptides in the mix were suppressing it. Peptides 
were then sequenced by tandem MS. 
Sequencing by tandem MS of trypsin-digested H4 provided minimal 
information due to excessive fragmentation of the N-terminus. I discovered one 
modified species at the H4 N-terminus, demonstrating that K5 and K10 are 
acetylated (Fig. 3.23, Table 2). 
Tandem MS of PA-trypsin-digested H4 provided extensive sequence 
coverage (Fig. 3.7E). The data did not suggest the presence of additional PTMs 
in the core domain or C-terminus of H4. MALDI-TOF demonstrated multiple 
modification states for peptides 1–15 and 16–21 (Fig. 3.24A and 25A, Table 2).  
Peptide 1-15 had the following sequence: AKGKKSGEAKGSQKR, which 
contains 5 lysines and an N-terminal alanine, all of which can be modified.  The 
number of modifiable amino acids made it difficult to interpret these spectra, so I 
relied on Edman data to make assignments.  For example, modifications were 
first assigned to A1 and K4 because these amino acids are found predominantly  
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TABLE 2. Posttranslational modifications are present at 
the N-terminus of Histone H4 
Digest Modified Peptidea 





AKGSQKRQ17Kme318Kme3VLRE (9-22)  
A10KacGSQKRQ17Kme318Kme3VLRE (9-22)  















a N-terminal peptides resulting from each digest were sequenced by tandem MS. 
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       b2   b3   b4  b5          b6     
AcK
Figure 3.23.  Histone H4 lysines 5 and 10 are acetylated.  H4 tryptic peptide 5-14 (KSGEAKGSQK) was sequenced by 
tandem MS.  Ion pairs y4-y5 and b5-b6 show that K10 is acetylated.  Ion pair y9-y10 shows that K5 is acetylated.  The 
presence of the acetyl immonium ion (m/z 126.09) supports the assigment of acetylation.  m/z 552.32+; 






Figure 3.24.  Histone H4 peptide 1-15 is present in multiple modification states.  
Propionylated H4 was digested with trypsin and fractionated by HPLC.  
(A)  MALDI-TOF data were acquired for 5 HPLC fractions.  M is the molecular ion 
mass of peptide 1-15 (AKGKKSGEAKGSQKR, MW 1559 Da).  Sequencing by 
tandem MS of 5 of these peaks (B-F) confirm that they represent peptide 1-15.  
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Figure 3.24B.  Histone H4 alanine 1 and lysines 2, 4, and 10 are modified.  This spectrum of the peak labeled M + 308 Da 
represents two modified species of peptide 1-15:  A1me1K2acGK4acKSGEAK10acGSQKR (y6", y7", y9", y10", y13", b2", 
and b5") and A1me1K2me2GK4acKSGEAKGSQKR (y6', y7', y9', y10', y11', y13', b2', b4', b5').  The b2 ion and y13-14 ion 
pair demonstrate that lysine 2 can be either acetylated or dimethylated.  Modified residues are shown in red.  m/z 934.72+; 
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Figure 3.24C.  Histone H4 lysine 4 is acetylated.  Tandem MS sequencing of the peak labeled M + 322 Da shows that K4 
may be acetylated.  The ion pair y11-y12 demonstrates this modification.  m/z 941.52+; theoretical MW = 1881.9 Da; 












































































Figure 3.24D.  Histone H4 alanine 1 is monomethylated and lysine 4 is acetylated.  The peak labeled M + 336 Da 
represents a modified species of peptide 1-15 in which both A1 and K4 are modified.  Compared to (C), the b ions are 
shifted +14 in this spectrum due to A1 monomethylation (see b2).  m/z 948.52+; theoretical MW = 1895.9 Da; 
measured MW = 1896.0 Da.
Ame1 K G Kac K S G E A K G S Q K R
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Figure 3.24E.  Histone H4 alanine 1 is monomethylated.  The peak labeled M + 350 Da represents a modified species of 
peptide 1-15 in which alanine 1 is monomethylated.  Compared to (C) and (D), y12-y14 are shifted +14 because K4 is 
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Figure 3.24F. Histone H4 alanine 1, lysines 2 and 4, and serine 6 are modified.  Tandem MS sequencing of the peak 
labeled M + 378 shows that propionic anhydride may also modify serines and threonines.  Propionylation of S6 is 




Figure 3.25.  Histone H4 peptide 16-21 is present in multiple modification states.  
Propionylated H4 digested with trypsin was fractionated by HPLC.  
(A)  MALDI-TOF data were acquired for 4 HPLC fractions, demonstrating that 
peptide 16-21 is present in several modification states.  Sequencing by tandem 
MS (B-F) confirmed that these peaks correspond to peptide 16-21 (QKKVLR), 
although, in some cases, glutamine rearranged to form pyroglutamic acid, 
resulting in the loss of ammonia (-17 Da).  M is the molecular mass of unmodified 
peptide 16-21 (771.51 Da).
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B.
Figure 3.25B.  Histone H4 lysine 18 is dimethylated.  The peak labeled M + 67 Da represents  a modified species of 
peptide 16-21 in which K17 is propionylated (+56), K18 is dimethylated (+28), and glutamine has rearranged to form 
pyroglutamic acid (-17).  The ion pairs y3-y4 and b2-b3 demonstrate the modification on K18.  m/z 419.92+; 
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Figure 3.25C.  Histone H4 lysines 17 and 18 are trimethylated.  The peak labeled M + 81 Da represents two modified 
species of peptide 16-21:  QK17me3KVLR (b2' and y4') and QKK18me3VLR (b2" and y4").  The lysine that is not 
trimethylated is propionylated (+56), and glutamine has rearranged to form pyroglutamic acid (-17).  Modified lysines are 
shown in red.  m/z 426.92+; theoretical MW = 851.5 Da; measured MW = 851.8 Da.
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      y4    y3   y2  y1
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Figure 3.25D.  Histone H4 glutamine 16 rearranges to form pyroglutamic acid.  The peak labeled M + 95 represents a 
species of peptide 16-21 in which both lysines are propionylated (unmodified).  Compared to the unmodified peptide, all of 
the b ions are shifted -17 Da, which is due to the loss of ammonia from glutamine.  m/z 433.42+; theoretical MW = 865.5 Da; 
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      b2    b3   
Figure 3.25E.  Histone H4 lysines 17 and 18 are monomethylated.  This tandem MS spectrum represents two modified 
species of peptide 16-21:  QK17me1KVLR (b2' and y4') and QKK18me1VLR (b2" and y4").  The lysine that is not 
monomethylated is unmodified (propionylated).  Modified lysines shown in red.  m/z 449.32+; theoretical MW = 897.5 Da; 
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Figure 3.25F.  Histone H4 lysines 17 and 18 are monomethylated.  This spectrum shows that there is modified species of 
peptide 16-21 in which both K17 and K18 are monomethylated.  m/z 456.32+; theoretical MW = 911.5 Da; 
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in their modified states.  Also, acetyl and trimethyl marks, both of which result in a 
+42 Da mass shift, were assigned based on Edman data. 
Sequencing of peptide 1–15 by tandem MS revealed a modification, 
K2me2, which was not observed by Edman degradation (Fig. 3.24B).  Two 
species of peptide 1-15 are represented on this spectrum at m/z 934.72+, 
A1me1K2acGK4acKSGEAK10acGSQKR and 
A1me1K2me2GK4acKSGEAKGSQKR.  Only one set of y1-y5 ions is present, 
indicating that the two species are equivalent, and unmodified, at the sequence 
GSQKR (H4 11-15).  There is also a single y14 ion, which, when subtracted from 
MH+, shows that both species are monomethylated at A1.  The two b2 ions 
demonstrate that K2 is dimethylated in one species and acetylated in the other.  
Two b5 ions show that both species have an acetylated lysine, which I assigned 
to K4.  Finally, two y6 ions are present 14 Da apart, and the mass difference 
between y5 and the two y6 ions indicates that K10 is acetylated in one species 
and propionylated in the other.  
Tandem MS sequencing of other modified species of peptide 1-15 
confirmed that K2, K4, and K10 can be acetylated (Fig. 3.24B-F). No 
modifications were observed on K5 or K14 with this digest.  Additional ions found 
on these spectra were due to cleavage at K2 and independent fragmentation of 
the peptide (KGKKSGEAK) resulting from this cleavage. 
Tandem MS analysis of peptide 16–21 (QKKVLR) demonstrated that K17 
is mono- and tri-methylated, and K18 is mono-, di-, and tri-methylated (Fig. 
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3.25B-F). The presence of only two modifiable lysines made the data easier to 
interpret than the spectra representing peptide 1-15; however, because the two 
lysines are adjacent to each other, only two ions, b2 and y4, can be used to 
distinguish between modification states.   
Tandem MS spectra representing peptide 16–21 were initially difficult to 
interpret because the mass of some of the modified peptides was 17 Da less 
than the theoretical mass (Fig. 3.25B-D). Closer examination of these spectra 
demonstrate that glutamine 16 (Q16) forms a cyclic compound between its free 
amine and amide carbon, resulting in the loss of ammonia and consequent 
molecular weight decrease of 17 Da. The cyclization of glutamine to form 
pyroglutamic acid has been characterized previously by MS [185]. 
MS analysis of Glu-C-digested H4 was focused on N-terminal peptides 1–
8 and 9–22. I was unable to acquire MALDI-TOF data for peptide 1–8 and found 
only one modified species by tandem MS, demonstrating that A1 is 
monomethylated and K4 is acetylated (Fig. 3.26, Table 2). Edman degradation 
suggests that this is the most abundant species of peptide 1–8. MALDI-TOF 
analysis of the fractionated Glu-C digest showed that peptide 9–22 is present in 
multiple modification-states (Fig. 3.27A). Tandem MS sequencing of peptide 9–
22 illustrated the combinations in which K10ac, K17me, and K18me may be 
present (Fig. 3.27B-F, Table 2).  Modified peptide 9-22 was observed as either a 
+4 or +5 species, which complicated the interpretation of these spectra.  I was 

















































Figure 3.26.  Histone H4 alanine 1 is monomethylated and lysine 4 is acetylated.  H4 was digested with endoproteinase 
Glu-C, producing peptide 1-8 (AKGKKSGE).  A1 monomethylation is demonstrated by ion pair y7-y8, and K4 acetylation is 
demonstrated by ion pairs b3-b4 and y4-y6.  m/z 430.72+; theoretical MW = 860.5 Da; measured MW = 860.4 Da.
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M + 14 Da               M + 42 Da
M + 70 Da  M + 84 Da
M + 126 Da
M + 98 Da  M + 112 Da
M + 84 Da
M + 28 Da    M + 42 Da            
Figure 3.27.  Histone H4 peptide 9-22 is present in multiple modification states. H4 digested by endoproteinase Glu-C 
was fractionated by HPLC. (A) MALDI-TOF data were acquired for 5 consecutive HPLC fractions. Peaks are separated by
14 Da, the molecular mass of a methyl group. M is the molecular ion mass of peptide 9-22 (1655 Da).  Sequencing by 
tandem MS (B-F) confirmed that peaks M + 42 Da, M + 56 Da, M + 70 Da, M + 84 Da, and M + 126 Da correspond to 
peptide 9-22 (AKGSQKRQKKVLRE).  The remaining peaks were incompletely sequenced.
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       b2                                b7    b8   b9 b10  
Figure 3.27B.  Histone H4 lysine 10 is acetylated and lysine 17 is trimethylated.  The peak labeled M + 42 Da represents 
two modified species of peptide 9-22:  AK10acGSQKRQKKVLRE (b2", y11", y12") and AKGSQKRQK17me3KVLRE 
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Figure 3.27C.  Histone H4 lysine 10 is acetylated and lysine 18 is monomethylated.  The peak labeled M + 56 Da 
represents a modified species of peptide 9-22 in which both K10 and K18 are modified.  Although this spectrum is 
incomplete, the presence of the b2 and y12-y13 ions indicate that K10 is acetylated, and the y5 ion suggests that K18 is 
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y13 y12  y11 y10   y9                 y6                y5                  y4   
       b2    
Figure 3.27D.  Histone H4 lysine 17 is trimethylated and lysine 18 is dimethylated.  The peak labeled M + 70 Da 
represents a modified species of peptide 9-22 in which both lysine 17 and 18 are modified.  These modifications are 






















Figure 3.27E.  Histone H4 lysines 17 and 18 are trimethylated.  The peak labeled M + 84 Da was sequenced, and ion 
pairs y4-y5 and y5-y6 demonstrate that K17 and K18 are modified.  m/z 348.85+; theoretical MW = 1740.0 Da; 
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Figure 3.27F.  Histone H4 lysine 10 is acetylated and lysines 17 and 18 are trimethylated.  The peak labeled M + 126 Da 
was sequenced by tandem MS, and the b2 ion shows that K10 is acetylated.  The y3 and y6 ions show that the additional 
+84 Da fall on the sequence KKV, which we assign as trimethyl K17 and K18.  m/z 446.44+; theoretical MW = 1782.0 Da; 
measured MW = 1782.6 Da.    
A Kac G S Q K R Q Kme3 Kme3 V L R E
              y12  y11 y10         y8           y6                                            y3          y1
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following species were not assigned: M + 14 Da, M + 28 Da, M + 98 Da, and M + 
112 Da.   
Two modified species of peptide 9-22 were observed at 425.44+, 
represented by the M + 42 Da peak: AK10acGSQKRQKKLVRE and 
AKGSQKRQK17me3KLVRE (Fig. 3.27B).  The presence of two b2 and y12 ions 
shows that K10 is acetylated in one species and unmodified in the other.  The 
presence of the b8 ion for the species unmodified at K10 shows that the 
additional +42 Da must fall on the sequence KKVLRE (H4 17-22).  Only one set 
of y3-y5 ions is present, indicating that the two are equivalent, and unmodified, at 
the sequence KVLRE (H4 K18-22).  Therefore, K17 must be trimethylated in the 
second modified species. 
The significance of these PTMs and the combinations in which they are 
present is currently unknown, but functional studies of individual marks and their 
corresponding histone-modifying enzymes will enable us to interpret these data 
in a meaningful way in the future. 
 
Comparison of Posttranslational Modifications between Bloodstream-Form and 
Procyclic-Form Histones 
 
 All of the modifications observed in PF were also identified in BF, but the 
analysis of BF histones was more extensive and uncovered additional PTMs 
(Table 3) [165].  I cannot dismiss the possibility that these PTMs may also be  
TABLE 3.  Summary of Histone Modifications in Trypanosomes 
 Bloodstream Forms Procyclic Forms 
Histone N-terminus Acetyl Lysine Methyl Lysine N-terminus Acetyl Lysine Methyl Lysine 


















none A1me1 (>80%) a none none 
H3 S1acb K23b K32me3b 
K76me1, me2, me3b 
S1acb none K76me1, me2, me3b 
H4 A1me1 (60%)a, b K2 (2%)a, b 
K4 (73%)a, b 
K5 (7%)a, b 
K10 (7%)a, b 
 
K2me2b 
K17me1 (4%), K17me2  
(8%), K17me3 (9%)a, b 
K18me1 (6%), K18me2  
(4%), K18me3 (18%)a, b 
A1me1 (>80%) a, b K4 (80%)a, b 
K10 (10%)a 
 
K17me1 (<10%),  
K17me2 (<5%)a 
K18me1 (<10%),  
K18me3 (<5%)a 
 
a PTMs observed by Edman degradation.  The levels of acetylation and methylation, shown in parenthesis, were 
quantified by comparison to known standards.  Three trials were performed for BF H4, providing an error of +/-2%. 
b PTMs observed by tandem MS 
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present in PF given the opportunity to perform additional studies, so a direct 
comparison may not be possible with the current MS data.  However, Edman 
degradation data allowed us to draw some distinctions.  Analysis of histone 
PTMs showed that H2A K4, H2B K4, and H4 K2 and K5 are acetylated at low 
levels in BF, but not PF.  H4 K2 and K5 are adjacent to modified amino acids A1 
and K4, respectively, so it is possible that K2 and K5 acetylation modulates the 
effects of the major marks in BF, but not in PF, possibly by interfering with the 
binding of effector proteins.  This phenomenon is well-documented in other 
organisms [186].  Similarly H2A and H2B K4 acetylation may affect interactions 
between monomethylated A1 with its binding partner in BF. Also, 
monomethylation of A1, which was identified in both PF and BF, was found to a 
greater extent in PF:  more than 80% of PF H2A, H2B, and H4 were 
monomethylated at A1, while only 60% of BF histones were monomethylated at 
A1.  These results suggest that the downstream biological effects of H2A, H2B, 
and H4 N-terminal PTMs, especially N-methylation of A1, may be subtly different 
in PF and BF.  
Methylation of K17 and K18 also demonstrated lifecycle differences:  
trimethylation of K17 and dimethyation of K18 were not observed in PF histones. 
Additionally, less than 5% of PF H4 K18 was trimethylated, while 18% of BF H4 
K18 was trimethylated. It is possible that different permutations of K17 and K18 
methylation result in the binding of different effector proteins, or that they 
modulate the binding efficiency of a single effector protein.  Regardless, 
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differences in K17 and K18 methylation levels in PF and BF H4 suggest different 
biological outcomes for the two lifecycles.   
It is not unexpected that the differences between BF and PF are subtle.  
The observation that different PTMs are present in the two lifecycle stages 
warrants further investigation.  However, it should be noted that Edman 
degradation is not a sensitive technique, so PTMs observed in low abundance 




In this study, I attempted to identify the major covalent modifications 
present on the four core histones of BF T. brucei. All of the identified PTMs and 
the methods used to discover them are summarized in Table 3. The major 
obstacle to this endeavor was H3, because sequencing of this histone was 
incomplete. The N-terminus was blocked to Edman degradation, and minimal 
tandem MS data were acquired for modified N-terminal peptides. However, Qq-
TOF data of the H3 PA-trypsin and Asp-N digests suggested that several lysines 
at the H3 N-terminus can be modified. MALDI-TOF data of the PF H3 N-terminus 
also suggested that a number of PTMs were present in this lifecycle stage, 
although no tandem MS data were acquired to assign PTMs to their specific 
amino acids (C. Janzen, unpublished data).  
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  Although there is no T. brucei homologue to H3 K9, which is associated 
with heterochromatin when methylated, there are predicted homologues of 
modified lysines 4, 18, 23, 27, and 36 (T. brucei K4, K16, K19, K23, and K32) 
(Fig. 3.28D).  Sequencing of trypsin-digested H3 by tandem MS showed that T. 
brucei K23 is acetylated and K32 is trimethylated, the homologues of K27 and 
K36 in other organisms. K27 can be both methylated and acetylated, and K36 is 
methylated. In humans and other organisms, methylation of H3 K27 recruits the 
Polycomb group proteins, which mediate transcriptional silencing [187]. In S. 
cerevisiae, methylation of H3 K36 by Set2 is correlated with transcriptional 
activation [188].  Set2 has been shown to affect the process of transcription 
elongation through its association with the RNA polymerase II elongation 
complex [189]. 
I also found that H3 K76 in the core domain could be mono-, di-, or tri-
methylated. K76 is the homologue of H3 K79 in S. cerevisiae and has been 
associated with euchromatin when methylated.  H3 K76 di- and trimethylation 
and the responsible histone methyltransferases, DOT1A and DOT1B, have been 
studied in detail in T. brucei [166]. Deletion of trypanosome DOT1 proteins 
caused defects in cell cycle regulation and differentiation between lifecycle 
stages.  This study demonstrated that, while T. brucei may have homologues to 
histone modifications and corresponding histone-modifying enzymes in S. 
cerevisiae, the biological functions of these marks may be organism-specific. 
A.  H2A N-terminus alignment
B.  H2A C-terminus alignment
C.  H2B N-terminus alignment
D.  H3 N-terminus alignment
E.  H4 N-terminus alignment
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Figure 3.28.  Fig. 1. Sequence alignments of the N-termini of each core histone 
and the C-terminus of H2A. Identical residues are shaded. Important sites of 
homology, which are referred to in the text, are indicated by arrows. The 
sequence ruler, which is included when the sequences are concordant, is 
numbered according to the Homo sapiens sequence. Residues found to be 
acetylated in T. brucei histones are indicated with an (*) and methylated residues 
with a (*). A putative site of ubiquitination at the H2A C-terminus is indicated with 
a (*). (A) H2A N-terminus. (B) H2A C-terminus. (C) H2B N-terminus. 
(D) H3 N-terminus. (E) H4 N-terminus.  
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In a later chapter, I began to characterize trimethyl H3 K4 using a specific 
antibody.  Therefore, our efforts in this chapter were targeted toward identifying 
H3K4me3 by MS.  I was unsuccessful for two reasons:  1) the nature of the 
peptides produced by the various digests were not amenable to sequencing by 
tandem MS, and 2) the mark is most likely present in low abundance, so the 
signal may have been suppressed by more abundant peptides. H3 peptide 1-25, 
which was produced by the Asp-N digest, has 2 arginines and 8 lysines and was 
observed as a +5 species.  For these reasons, MS/MS data for modified peptide 
1-25 were uninterpretable.  The Glu-C (H3 1-5, SRTKE) and trypsin (H3 3-8, 
TKETAR) digests both produced K4-containing peptides that were small and 
hydrophilic.  It has been suggested that these peptides might elute immediately 
from the HPLC column prior to being analyzed by the mass spectrometer.  The 
unmodified PA-trypsin peptide 3-8 was observed, indicating that perhaps 
neutralizing the charge of K4 by propionylation reduced the hydrophilicity of the 
peptide, causing it to be retained on the HPLC column.  The low abundance of 
the K4 methyl mark also contributed to its elusiveness and was further 
complicated by the presence of H2A peptides, which were present at a higher 
concentration than H3 peptides.  
Next I investigated the PTMs on T. brucei histone H4.  It has been shown 
that the acetylation of the S. cerevisiae H4 N-terminus at K5, K8, K12, and K16 is 
classically associated with transcriptional activation for two reasons [9]. First, 
acetylation functions to decrease the positive charge of the histone tail, thereby 
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disrupting DNA-histone interactions and allowing for increased access to DNA by 
transcription factors [11].  Second, acetylated and unacetylated lysines serve as 
binding sites for effector proteins involved in transcriptional silencing or 
activation.  According to our alignment, S. cerevisiae K5, K12, and K16 
correspond to T. brucei K4, K10, and K14, all of which are acetylated (Fig. 
3.28E). Although the T. brucei H4 sequence diverges considerably from the 
extremely conserved H4 N-terminus of other organisms, 3 of the 4 lysines appear 
to be conserved.  Acetylation of T. brucei K4 and K10 suggests that the link 
between H4 N-terminal acetylation and transcriptional activity is conserved in an 
evolutionarily divergent organism. 
Importantly, in addition to the conserved acetylated lysines found at the H4 
N-terminus, there is an apparent homologue of the methylated H4 K20, T. brucei 
H4 K18 (Fig. 3.28E). Trimethyl H4 K20 is a marker of constitutive and facultative 
heterochromatin and is in competition with the hyperacetylated H4 N-terminus 
[190]. Monomethyl H4 K20 is present at active gene promoters in association 
with H4 hyperacetylation, which demonstrates that the degree of methylation may 
be associated with distinct transcriptional states [191]. I found that T. brucei H4 
K18 and the adjacent K17 may both be mono-, di-, or tri-methylated. K17 and 
K18 exist together in a number of different modification states (Table 2). It is 
unlikely that these different methylation levels are created by different 
methyltransferases because there are only 3 identifiable putative SET domain-
containing methyltransferases in the T. brucei genome [148]. Instead, it is more 
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likely that a single methyltransferase acts on both K17 and K18, and the degree 
of methylation is determined by cofactors acting on the methyltransferase. I 
cannot predict whether the degree of methylation or the combination of 
modification states in which K17 and K18 co-exist will result in distinct biological 
readouts. If so, the amount of variability would allow for intricately regulated 
downstream effects. 
Two modified lysines in the T. brucei H4 N-terminus, K2 and K5, did not 
have homologues in other organisms. I was especially interested in K2, which 
can be either acetylated or dimethylated. The modification of H4 K2 is very minor: 
Edman data showed that ~2% of H4 K2 is acetylated. MS/MS data showed that 
H4 K2 was dimethylated, but this modification was not observed during Edman 
analysis, so I expected that H4K2me2 was present in less than 1% of H4. 
Histones from other organisms possess a number of lysines that may be either 
acetylated or methylated. Chicken H3 K9, for example, is subject to both types of 
covalent modifications. Chromatin immunoprecipitation experiments showed that 
H3K9me3 is associated with inactive chromatin, whereas H3K9ac is found at the 
boundaries of heterochromatin [192]. The authors suggest that acetylation of H3 
K9 acts as an insulator against the propagation of heterochromatin, which is 
initiated by H3K9me3 and H3K9me3 binding proteins. This study demonstrates 
that acetylation and methylation of a single lysine may have antagonistic roles in 
the establishment of different chromatin states. Whether T. brucei H4 K2 is 
involved in determining chromatin structure is unknown, but I propose that the 
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dual modification status of this lysine makes it an interesting target for further 
characterization. 
The final point of interest at the H4 N-terminus is the N-methylation of A1, 
which was also observed in H2A and H2B. This is an unusual histone 
modification discovered recently in trypanosomatids [165,181]. Here, I also 
showed that A1 can be acetylated in H2A or dimethylated in H2B. I speculate that 
N-methylation of A1 in H2A, H2B, and H4 acts as a binding platform for an 
effector protein, and that binding may be modulated by neighboring marks (H4 
K2 and H2A and H2B K4 acetylation). 
Histones H2A and H2B are notable for the relatively few modifications 
found at their N-termini compared to other organisms. Both H2A and H2B begin 
with the sequence ATPK in T. brucei, and both are N-methylated at ~60% of A1 
and acetylated at ~1% of K4. Methylation of A1, but not acetylation of K4, was 
confirmed by tandem MS for both H2A and H2B. T. brucei H2A K4 is 
homologous to human H2A K5, a residue that is acetylated by Hat1 and may be 
associated with the deposition of newly synthesized histones into chromatin 
(Figure 3.28A) [193]. Additionally, H2B is acetylated at K12 and K16, neither of 
which is a homologue of lysines in other organisms (Fig. 3.28C). 
The H2A C-terminus contains 6 acetylated lysines (K115, K119, K120, 
K122, K125, and K128). Three of these, K120, K122, and K128, are probable 
homologues of lysines in other organisms, but the homologues of T. brucei K120 
and K128 do not appear to be modified (Fig. 3.28B). T. brucei H2A K122 aligns 
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with human H2A K119, the site of ubiquitination on this histone [183]. In other 
organisms, H2A ubiquitination is associated with transcriptional silencing. During 
mouse spermatogenesis, H2A ubiquitination is enriched in a region of the murine 
nucleus known as the sex body, a structure containing the heterochromatic X and 
Y chromosomes [194]. It was shown in HeLa cells that the H2A E3 ubiquitin 
ligase complex is composed of four members of the Polycomb group proteins, 
thereby suggesting a link between Polycomb-mediated silencing and H2A 
ubiquitination [195]. There is some evidence to suggest that the T. brucei H2A C-
terminus is ubiquitinated — the molecular weight of an H2A peptide 107–133 
corresponds to a modified species that has one ubiquitinated and three 
acetylated lysines. Interestingly, T. brucei K122 is the only lysine at the H2A C-
terminus that is adjacent to a possible phosphorylation site, S123. In other 
organisms, ubiquitinated lysines at the H2A and H2B C-termini are adjacent to 
phospho-acceptor sites. It has been suggested that phosphorylation influences 
ubiquitination and de-ubiquitination of its neighboring lysine and also influences 
whether effector proteins bind ubiquitinated lysine [186]. Based on our data and 
the alignment of the H2A C-terminus with the C-terminus of H2A from other 
organisms, I propose that T. brucei H2A K122 can be ubiquitinated. 
A similar study identifying covalent histone modifications in PF was 
published recently (Table 3) [165]. Analysis by Edman degradation allowed us to 
draw some direct comparisons (see Results), but I cannot make many 
comparisons based on the MS data.  A number of acetylated lysines were found 
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in BF histones by MS that were not present in PF histones (H2A K122, H2B K12 
and K16, H4 K2 and K5), but I did not attribute these to lifecycle differences. 
Sodium butyrate, a histone deacetylase inhibitor, was used during histone 
purification from BF trypanosomes, but not from PF, which may account for the 
observed variation. I also refrained from drawing comparisons between BF and 
PF of the H4 N-terminus because it was examined in more detail in this study: 
the less abundant methyl mark found in BF (K2) was only uncovered following 
HPLC fractionation of H4 Glu-C and PA-trypsin digests. A more direct 
comparison of histone modifications in BF and PF would require isotopic labeling 
and mixing experiments, so that histones from both stages may be co-purified 
and analyzed simultaneously. 
While this study was in progress, a paper characterizing the PTMs on H4 
from Trypanosoma cruzi was published [181].  The N-terminus of H4 is nearly 
identical in the two closely related organisms.  Using MS/MS, the authors found 
that alanine 1 was monomethylated, lysines 4, 10, 14, and 57 were acetylated, 
lysine 18 is monomethylated, and arginine 53 is dimethylated.  I examined our 
data for evidence of R53 methylation and K57 acetylation, but neither mark was 
found.  Perhaps this reflects species-specific variation of histone PTMs.  A 
number of marks discovered in our study were not found in T. cruzi, including K2 
and K5 acetylation, K2 dimethylation, K17 methylation, and K18 di- and tri-
methylation.  As with PF histones, it is hard to say whether these differences are 
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real or whether the marks were overlooked by the MS methods employed by the 
authors.   
The study of T. cruzi histones also looked at bulk acetylation and 
methylation by in vivo labeling of live trypanosomes with acetyl and methyl 
donors [3H]-acetic acid and L-[methyl-3H]-methionine, respectively [181].  It was 
shown that H2A, H4, and, to a lesser extent, H3, were labeled with  [3H]-acetic 
acid; H3, H2B, and, to a lesser extent, H4, were labeled with L-[methyl-3H]-
methionine.  Our results are in agreement with the findings for H2A, H3, and H4;  
however, methylation of H2B was not observed in T. brucei, so perhaps this 
reflects species-specific variation of histone PTMs as well. 
In higher eukaryotes, histones are highly conserved proteins. The extreme 
sequence divergence of T. brucei histones makes them interesting targets for 
phylogenetic comparisons. I demonstrated that, despite the sequence 
divergence, the locations of several modified residues are similar. The 
information compiled here provides a number of starting points for functional 
studies, some of which we are beginning to undertake.  Future work will focus on 
identifying the modifications that play key roles in transcriptional regulation in 
trypanosomes. 
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Chapter 4.  Investigating the Target of the  




Sequencing of the T. brucei genome identified 7 putative histone 
deacetylases, including 3 SIR2-related proteins, based on sequence homology 
[148]. To be able to analyze the function of individual histone modifications, I first 
needed to identify the histone-modifying enzymes that create these marks. I 
chose to focus on T. brucei SIR2 related protein-1 (TbSIR2RP-1) for two reasons. 
First, S. cerevisiae SIR2, an H4 K16ac deacetylase, is involved in establishing 
and propagating heterochromatin at telomeres and subtelomeric regions [29].  
Because many VSGs are subtelomeric and are subject to strictly controlled 
transcriptional silencing, it seemed reasonable to think that TbSIR2RP-1 might 
play a role in regulating VSG expression, although a recent study showed that 
disruption of TbSIR2RP-1 does not cause de-repression of silent VSGs [170].  
Slight de-repression at non-ES subtelomeric RNA pol I-driven reporter cassettes 
was observed.  Secondly, it was shown that cells over-expressing TbSIR2RP-1 
demonstrated increased sensitivity to micrococcal nuclease following DNA 
damage, compared to wild-type cells, indicating that this enzyme influences 
chromatin structure [172]. The same study showed that TbSIR2RP-1 has in vitro 
deacetylase activity against T. brucei histones.  I analyzed H4 from T. brucei 
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mutants lacking the SIR2-related protein 1, and conclude that TbSIR2RP-1 is 




Isolating Histones from a ΔTbsir2rp-1 Cell Line 
 
A ΔTbsir2rp-1 cell line was created by replacing endogenous TbSIR2RP-1 
alleles with drug resistance markers, which were targeted to the TbSIR2RP-1 
locus using endogenous UTRs (Fig. 4.1;  constructs provided by M. Hoek).  The 
ΔTbsir2rp-1 cells were amplified in rats, collected from rat blood by centrifugation 
following exsanguination, and were used as starting material for the purification 
of histones using the protocol developed for BF 221wt cells. The elution profile of 
ΔTbsir2rp-1 histones obtained during fractionation by HPLC did not demonstrate 
significant differences from the BF 221wt profile (Fig. 4.2).  Any differences in the 
elution profiles were most likely due to the use of different columns for each 
sample.  To confirm the purity of the histones, HPLC fractions were analyzed by 
Coomassie stain (Fig. 4.3).  The identity of the histones in each HPLC fraction 




Figure 4.1.  Replacement of two TbSIR2RP-1 Alleles Demonstrated by Southern 
blot.  To confirm knockout, gDNA from BF 221 wt cells and 3 clones, 
MH166.6.167.1-3, were digested with NcoI and NdeI and probed with TbSIR2RP-1.  
Expected bands at 5.0 and 4.6 kb were observed for NcoI and NdeI digest, 
respectively, in wt cells, but no bands corresponding to TbSIR2RP-1 were observed 
for clones.













Figure 4.2.  HPLC Elution Profile of ∆Tbsir2rp-1 Knockout Histones.  Crude histone preparation was fractionated by 
RP-HPLC.  Absorbance 214 nm.  Additional peaks did not contain histones.  CAP15 = corset-associated protein 15. 
CAP15
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Figure 4.3.  SDS-PAGE of HPLC-purified ∆Tbsir2rp-1 histones.  Fractions 54 
and 55 contain H2A and H3;  fractions 58-63 contain H4;  fractions 62 and 63 
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Investigating the Target of TbSIR2RP-1 Deacetylase 
 
SIR2 in yeast and other organisms is an H4 deacetylase, so ΔTbsir2rp-1 
H4 was examined first for increased levels of acetylation. ΔTbsir2rp-1 H4 was 
analyzed by Edman degradation, but, surprisingly, no differences in the 
acetylation pattern were observed (Table 4, Fig. 4.4).  No additional PTMs were 
identified on H4 besides those at the N-terminus, so I concluded that TbSIR2RP-
1 is either not an H4 deacetylase or its loss is very efficiently compensated for by 
another deacetylase. 
To determine whether any of the histones were the in vivo target of the 
putative TbSIR2RP-1 deacetylase, purified histones from 221wt and ΔTbsir2rp-1 
were analyzed on a TAU gel (Fig. 4.5).  A TAU gel allows for the separation of 
proteins based both on size and charge.  Therefore, phosphorylation and 
acetylation, both of which modify the charge of a protein, would be visible as 
distinct bands from the unmodified species.  The more positively-charged 
unacetylated species migrates closer to the bottom of the gel than the acetylated 
species.  I expected that ΔTbsir2rp-1 histones would be more highly acetylated, 
which would be demonstrated by an upward shift on the gel.   
H2A, H2B, and H3 were analyzed on a TAU gel with 15% polyacrylamide.  
H2B is represented on the gel by only one band, and there is no apparent 
difference in the migration pattern of H2B from wt versus ΔTbsir2rp-1 cells.  The 
band most likely represents unmodified H2B because the three modified lysines  
Figure 4.4.  Edman degradation of histone H4 from ∆Tbsir2rp-1 cells shows that 
TbSIR2RP-1 is not an H4 deacetylase.  The PTH HPLC trace of cycles 2, 4, 5, 
and 10 show that 2% of K2, 73% of K4, 5% of K5, and 7% of K10 are acetylated.  
These values do not represent a significant change from the acetylation levels of 
H4 from wt cells, suggesting that TbSIR2RP-1 does not deacetylate the H4 


















TABLE 4. Quantification of posttranslational 
modifications at the H4 N-terminus from 
wild-type and ΔTbsir2rp-1 cellsa 




A1me1 60 60 
K2ac 2 2 
K4ac 73 73 
K5ac 7 5 
K10ac 7 7 
K17me1, 2, 3 4, 8, 9 -- 
K18me1, 2, 3 6, 4, 18 -- 
 
a  H4 purified from wild-type and ΔTbsir2rp-1 cells was sequenced by Edman 
degradation. The levels of acetylation and methylation were quantified by 
comparison to known standards. 
b Data for wild-type H4 are the average of three trials. 
c ΔTbsir2rp-1 H4 was sequenced once using conditions that were not optimal for 







Figure 4.5.  Histones from BF 221wt cells (wt) and BF ∆Tbsir2rp-1 cells (ko) on 
TAU gel (H2A/H3 and H2B on 15% PAGE; H4 on 20% PAGE).  No obvious 
differences were observed between the migration pattern of 221wt and 
∆Tbsir2rp-1  histones.
H2A + H3               H2B                       H4
  wt        ko          wt        ko               wt       ko
H2A
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(K4, K12, and K16) that I previously identified were acetylated at very low levels 
(Table 3).   
H2A and H3 are present in the same lane because they could not be 
separated from each other by HPLC.  Multiple bands at the top of this lane most 
likely represent H2A, which has 6 acetylated lysines at the C-terminus that can 
be found in different combinations.  Upward mobility shifts of two subtle bands, 
which cannot be seen on this reproduction, between wt and ΔTbsir2rp-1 H2A and 
H3 suggest that TbSIR2RP-1 may act as a deacetylase for one or both of these 
histones.  The likely candidate is H2A because it has multiple acetylated lysines, 
while H3 has only one. 
H4 was analyzed on a TAU gel with 20% polyacrylamide because 
separation could not be achieved on a 15% polyacrylamide gel.  Two bands are 
present for both wt and ΔTbsir2rp-1 H4.  The darker band most likely represents 
the singly acetylated species of H4.  H4 analysis by Edman degradation showed 
that 73% of K4 is acetylated, so the singly acetylated H4 is the major species.  
The lighter band, which migrates directly beneath the darker one, most likely 
represents the minor, unacetylated species.  No differences in the two bands 
were observed between wt and ΔTbsir2rp-1 H4, which confirms that TbSIR2RP-1 
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Discussion 
 
To begin characterizing histone modifying enzymes in trypanosomes, I 
chose to study the SIR2 homologue, TbSIR2RP-1.  H4 from a ΔTbsir2rp-1 cell 
line was analyzed by Edman degradation and had the same acetylation levels as 
wildtype H4, indicating that TbSIR2RP-1 is not an H4 deacetylase.  There was a 
possibility that two additional SIR2-related proteins in T. brucei, TbSIR2RP-2 and 
3, might perform functions redundant to TbSIR2RP-1, masking the effects of 
knocking out the putative deacetylase.  However, it was shown that TbSIR2RP-2 
and 3 localize to the mitochondrion, while only TbSIR2RP-1 is found in the 
nucleus [170].  Therefore, I think it is unlikely that TbSIR2RP-2 and 3 perform 
functions that are redundant to TbSIR2RP-1.  I concluded that TbSIR2RP-1 is not 
an H4 deacetylase. 
An earlier study of TbSIR2RP-1 showed in vitro that the purified enzyme 
acts as a deactylase of trypanosome histones [172].  Purified histones labeled 
with a radioactive acetyl donor, [3H] acetyl-CoA, by yeast H4 acetyltransferase, 
HAT1, were incubated with TbSIR2RP-1.  The release of [3H]acetyl groups was 
observed for each of the four major histones.  I did not think our results contradict 
this work because it is well-known that enzymes demonstrate different, and 
perhaps broader, specificity in vitro than they do in vivo.  This study shows that 
TbSIR2RP-1 has deacetylase activity, but its target has yet to be identified. 
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Comparing purified histones from BF 221wt and ΔTbsir2rp-1 cells on a 
TAU gel demonstrated minor differences in H2A and H3, but not H4 or H2B.  The 
two upward band shifts that were observed in ΔTbsir2rp-1 H2A and H3 were 
consistent with the presence of more highly acetylated species.  However, more 
work is needed to verify that either H2A or H3 is the target of TbSIR2RP-1.  For 
example, purified H2A from wildtype and ΔTbsir2rp-1 cells may be labeled with 
propionic acid or deuterated propionic acid and mixed.  MALDI-TOF analysis of 
the trypsinized sample will show C-terminal H2A peptide 107-133 in its various 
acetylated states.  The peaks corresponding to either wildtype or ΔTbsir2rp-1 
H2A will be evident from their masses, and the intensity of the peaks may be 
compared to determine whether acetylated species are less abundant in 
ΔTbsir2rp-1 H2A.  This would illustrate whether TbSIR2RP-1 is an H2A 
deacetylase. 
Finally, although this study was initiated with the idea that TbSIR2RP-1 
might be involved in the regulation of VSG expression, two separate studies have 
shown that TbSIR2RP-1 does not affect antigenic variation [170,171].  In the first 
study, both alleles of TbSIR2RP-1 were disrupted in a cell line containing a 
luciferase marker downstream of an inactive ES promoter [171].  There was no 
increase in luciferase expression in the ΔTbsir2rp-1 cell line, indicating that 
TbSIR2RP-1 is not involved in silencing at the inactive ES in BF.  It is thought 
that different mechanisms control silencing of the ES in BF and PF [149].  The 
authors differentiated wildtype and ΔTbsir2rp-1 cells to PF, but again found no 
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difference in luciferase expression at the ES between the two cell lines.  The 
second study similarly used a reporter construct in both wildtype and ΔTbsir2rp-1 
cells to show that TbSIR2RP-1 is not involved in ES silencing [170].  However, 
using a reporter construct downstream of a repressed promoter 2 kb from a 
telomere, the authors show that reporter expression was increased following 
disruption of both TbSIR2RP-1 alleles, indicating that TbSIR2RP-1 does play a 
role in telomeric silencing.  It seems that, although TbSIR2RP-1 is not an H4 
deacetylase, it remains a player in the establishment of silent chromatin at the 
telomere. 
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Chapter 5.  Histone variant H2Bv replaces H2B in nucleosomes enriched 




 In other organisms, histone PTMs have been studied for their roles in a 
variety of biological processes.  Causal relationships between the various histone 
modifications led to the ‘trans histone’ cross-talk hypothesis, which in part states 
that PTMs on one histone may prohibit or be required for PTMs on another 
histone [61].  In one famous instance of cross-talk between histones, 
ubiquitination of histone H2B lysine 123 in S. cerevisiae was shown to be 
required for H3 lysine 4 and 79 methylation [62,63].  Furthermore, these 
modifications are linked to transcription elongation, as it has been shown that the 
elongating RNA polymerase II and its binding partners form a platform for the 
recruitment of H3 K4 and K79 methyltransferases Set1 and Dot1, respectively, 
following H2B ubiquitination (reviewed in [65]). 
 The addition of PTMs to a histone is one mechanism for providing diversity 
to a nucleosome and allowing for a variety of biological readouts.  A second 
mechanism for providing diversity is the substitution of histone variants for 
canonical histones in the nucleosome [71]. Histone variants have previously been 
identified for each of the four major histones in trypanosomes [173,174].  
Preliminary work on T. brucei histone variant H2Bv showed that H2Bv is a single 
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copy gene that is essential for viability [174].  Also, histone variant H2AZ co-
immunoprecipitates with H2Bv, demonstrating that the two variants form a dimer 
within a nucleosome.  I continued the characterization of H2Bv by identifying 
PTMs present on the histone variant.  
 After identifying many of the histone PTMs in T. brucei, I began to 
examine the functional relationships between individual marks using sequence 
alignments as a guide.  Here, I examined the sequence homology between T. 
brucei H2B, H2Bv, and H2B from other organisms and found that H2Bv has a 
homologue (lysine 129) to S. cerevisiae H2B K123, but T. brucei H2B does not 
(Fig. 5.3).  Based on the alignment, I hypothesized that H2Bv K129 is 
ubiquitinated and required for H3 K4 and K76 methylation.  In order to assay for 
H3 K4 methylation, I raised a specific antibody against an H3K4me3-containing 
peptide and began to characterize this mark. 
Although I found that H2Bv K129 is not ubiquitinated, I was able to show 
that H2Bv specifically associates with H3 that is trimethylated at K4 and K76.  
These data suggest that H3 K4 and K76 methylation in trypanosomes is 
regulated by a novel mechanism, possibly involving the replacement of major 












Anti-H3K4me0 and H3K4me3 Antibodies 
  
 Although I was unable to identify many PTMs at the T. brucei H3 N-
terminus in Chapter 3, a sequence alignment of the H3 N-termini suggested that 
T. brucei H3 K4, a possible homologue of the well-studied methyl H3 K4 in other 
organisms, was methylated (Fig. 3.28D).  Therefore, I raised antibodies against 
H3 peptide 2-9, RTKETART, that was unmethylated or trimethylated at K4.  
Purification of the anti-H3K4me3 antibody was complicated by its overlapping 
specificity for H3K4me3- and H3K76me3-containing peptides. To purify anti-
H3K4me3 antibody with diminished H3K76me3 binding affinity, H3K4me3 
antiserum was twice depleted on a column coupled to an H3K76me3 peptide.  
H3K4me0 and H3K4me3 antisera were then affinity purified on columns coupled 
to their corresponding peptides. 
 The specificity of the two antibodies was confirmed by Western blot 
analysis (Fig. 5.1).  First, a blot containing purified histones, the identity of which 
were verified by MS, was incubated with the anti-H3K4me3 antibody to show that 
the antibody only recognized H3, but not H2A, H2B, or H4 (Fig. 5.1A).  Second, 
the two antibodies were subject to peptide competition by pre-incubating them 
with no peptide, H3K4me0-, H3K4me3-, H3K76me0-, and H3K76me3-containing 


























B.    10 ng/ml peptide
Figure 5.1.  Specificity of anti-Histone H3 lysine 4 unmethylated and trimethyl 
antibodies.  (A)  Crude histone extract and purified histones (verified by MS) were 
loaded on a Western blot and probed with anti-H3K4me3, anti-H3, and anti-H4 
antibodies.  The blot shows that the anti-H3K4me3 antibody only recognizes H3, 
and not other histones.  (B) Anti-H3K4me3 and me0 antibodies were 
pre-incubated with no peptide, H3K4me0, H3K4me3, H3K76me0, and H3K76me3 
peptides prior to incubation on a Western blot.  Both antibodies bind only their 
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incubated with the antibodies, which showed that both antibodies bind only their 
corresponding peptide.   
 
Localization of H3 with Unmethylated and Trimethylated Lysine 4 
 
 Immunofluorescence using the anti-H3K4me0 and H3K4me3 antibodies in 
wildtype BF and PF cells illustrated the localization of these marks.  In BF cells, 
both H3K4me0 and H3K4me3 were distributed throughout the nucleus, with the 
exception of the nucleolus (Fig. 5.2A).  Staining with the anti-H3K4me3 antibody 
produced a punctate staining pattern in BF cells, indicating that there are some 
regions within the nucleus where trimethyl H3 K4 is concentrated.  In PF cells, 
again, both H3K4me0 and H3K4me3 are distributed throughout the nucleus (Fig. 
5.2B).  However, both demonstrate regions of higher intensity staining, indicating 
that there may be foci where unmethylated and trimethyl H3 K4 are concentrated. 
 
Sequence Homology of T. brucei Histones H2B and H2Bv  
  
T. brucei histone variant H2Bv shares 38% sequence homology with H2B 
[174].  The region of greatest similarity is at the C-terminus, where both histones 
also share significant sequence homology with H2B from other organisms (Fig. 
5.3).  Interestingly, the C-terminal tails of H2B (5´ –SHASS) and H2Bv (5´ –
AKYNASREEAYSKVL) differ such that H2Bv shares greater sequence homology  
   H3K4                                                       DAP I                                                     Tubulin            A.
anti-H3K4me0 ab
anti-H3K4me3 ab
Figure X.  Localization of Histone H3 unmethylated and trimethyl lysine 4.  Anti-H3K4me0 and me3 antibodies were used to stain
cells to determine their localization pattern.   




Figure 5.2.  Localization of unmethylated and trimethyl histone H3 lysine 4.  The cell in the top panel is stained with 
anti-H3K4me0 antibody, and the cell in the bottom panel is stained with anti-H3K4me3 antibody.  Cells are also stained 
with DAPI and tubulin so that DNA and the cytoskeleton, respectively, may be visualized.  (A)  Wildtype bloodstream form 
cells are stained with the two antibodies, demonstrating that unmethylated H3 K4 is evenly distributed throughout the 
nucleus.  Trimethyl H3 K4 may also be found throughout the nucleus, but has a more speckled appearance. 
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B. Histone H3 lysine 4                               DAPI                                            tubulin
Anti-H3K4me0 ab
Anti-H3K4me3 ab
Figure 5.2B.  Wildtype procyclic form cells are stained with anti-H3K4me0 and me3 antibodies.  Both unmethylated 
and trimethyl H3 K4 are found distributed unevenly throughout the nucleus.  
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Figure 5.3.  Sequence alignment of T. brucei histones H2B and H2Bv with H2B from other organisms.  Identical residues 
are shaded.  The sequence ruler is numbered according to the S. cerevisiae sequence.  An arrow points to T. brucei  H2Bv 
K129, which is homologous to the ubiquitinated K123 from S. cerevisiae.
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with the H2B consensus sequence from other organisms than T. brucei H2B.  
Apart from the C-terminus, H2Bv shares limited sequence homology with the 
H2B consensus. 
S. cerevisiae H2B lysine 123 is famously known as a site of ubiquitination, 
which is required for H3 K4 and K79 methylation [62,63].  The H2B sequence 
alignment shows that T . brucei H2Bv lysine 129 is homologous to S. cerevisiae 
H2B K123, but no such homologue exists in T. brucei H2B.  Based on this 
alignment, I hypothesized that H2Bv lysine 129 could be ubiquitinated and 
required for H3 K4 and K76 methylation. 
 
Purification of H2Bv and Identification of Posttranslational Modifications 
  
To investigate whether H2Bv K129 is ubiquitinated, H2Bv-FLAG was first 
affinity purified from 1.0x1010 BFJEL18 cells using the purification protocol 
described in Chapter 3.  Following acid extraction, the sample was incubated on 
anti-FLAG affinity resin and eluted by boiling the resin in 2x SDS-PAGE loading 
buffer.  The entire sample was then analyzed by Coomassie stain (Fig. 5.4).  
Several bands were present, all of which were identified by MS, including H2Bv-
FLAG (16.7 kDa), the heavy (50 kDa) and light (25 kDa) chains of the 
immobilized M2 antibodies that dissociated from the gel during the elution 
process, and histones (11-15 kDa) that co-immunoprecipitated with H2Bv-FLAG. 
In order to look for ubiquitinated (25.1 kDa) or otherwise modified H2Bv-FLAG,  
Figure 5.4.  Purification of Histone H2B variant.  FLAG-tagged H2Bv was affinity 
purified on resin conjugated to anti-FLAG M2 antibody.  H2Bv was eluted by 
boiling the resin in SDS loading buffer.  The eluate was loaded on an SDS-PAGE 
gel and stained with Coomassie.  The identity of the bands on the gel were 
confirmed by MS.  In addition to H2Bv-FLAG (16.7 kDa), histones and anti-FLAG
ab were also eluted from the resin.  To look for ubiquitinated H2Bv-FLAG 
(~25.1 kDa), eight gel slices were cut between the band representing H2Bv-FLAG 
and ~35 kDa.  These gel slices were digested with trypsin and analyzed by 
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which would migrate more slowly than the unmodified H2Bv-FLAG, the region of 
the gel between ~17 and 35 kDa was cut into 8 gel slices, trypsinized, and 
analyzed by tandem MS.  Gel slices #1-7 contained H2Bv-FLAG tryptic peptides 
and provided adequate sequence coverage by MS (Fig. 5.5).  Unmodified K129 
was observed in H2Bv peptide 118-129, HAMSEGTKAVAK, which was produced 
as the result of a partial digest. 
Posttranslational modifications were identified at the H2Bv N-terminus, 
including acetylation of lysines 7 and 19 and methylation of lysines 15 and 17 
(Fig. 5.6A-G, Table 5).  H2Bv peptide 8-17 was observed at m/z 525.522+ and 
532.632+, which represents a +28 and +42 Da mass shift from the unmodified 
peptide (Fig. 5.6C-D).  The +28 Da mass shift was due to the presence of a 
dimethyl group on K15.  The +42 Da mass shift was also assigned to K15, and 
was identified as a trimethyl group by the presence of the MH+-59 ion.  H2Bv 
peptide 8-19, observed at m/z 646.562+, showed that K17 was trimethylated 
because the y2-y4 ions provide a mass difference (m/z 227.17) expected for a 
trimethyl lysine (m/z 227.17), not an acetyl lysine (m/z 227.13)(Fig. 5.6E).  No 
PTMs were identified on H2Bv apart from at the N-terminus.  This may be due to 
the limitations of the trypsin digest, which excessively fragments this basic 
protein.  However, the H2Bv results are consistent with our findings that the four 
major histones also have few PTMs, most of which are at the N-terminus. 
 Ubiquitin covalently attaches to lysine at its C-terminus.  Ubiquitination can 

























Figure 5.5.  Histone H2Bv sequence with regions for which tandem MS data were 
acquired following trypsin digestion shown in red. 
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TABLE 5. Posttranslational modifications are present at 
the N-terminus of Histone H2Bv 










a Tryptic peptides were sequenced by tandem MS, and peptides that have 












Figure 5.6.  The N-terminus of histone H2B variant has several posttranslational modifications.  H2Bv was digested with 
trypsin, and the resulting peptides were sequenced by tandem MS.  (A)  Sequencing of peptide 5-15 (GGKRPLPLGGK) 
shows that K7 is acetylated.  This is demonstrated by b3 and y7-y10 ions.  m/z 561.52+; theoretical MW = 1121.7 Da; 
measured MW = 1122.0 Da.    


































































G G Kac R P L P L G G K
y10                        y7         y5        y3    y2    


































































G G Kac R P L P L G G Kme3 G K
                              y9         y7   y6  y5  
                      b3   b4         b6        b8    b9                      b11  b12
Figure  5.6B.  Sequencing of H2Bv tryptic peptide 5-17 (GGKRPLPLGGKGK) shows that K7 is acetylated and K15 is 








































































R P L P L G G Kme2 G K
       y8  y7   y6  y5   y4    
             b3  b4  b5           b7                 
Figure 5.6C.  Sequencing of H2Bv tryptic peptide 8-17 (RPLPLGGKGK) shows that K15 is dimethylated.  m/z 525.522+; 




Figure 5.6D.  Sequencing of H2Bv tryptic peptide 8-17 (RPLPLGGKGK) shows that K15  is trimethylated, which is 
demonstrated by ion pair b7-b8.  The presence of the MH+-59 ion supports the assignment of trimethylation.  m/z 532.62+; 
theoretical MW = 1064.6 Da; measured MW = 1064.2 Da.    



































































R P L P L G G Kme3 G K
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R P L P L G G Kme3 G Kme3 G K
y11 y10 y9        y7                                 y4                        y2   
       b2  b3        b5                                b8    b9                b10  b11
Figure 5.6E. Sequencing of H2Bv tryptic peptide 8-19 (RPLPLGGKGKGK) showed that both K15 and K17 are 
trimethylated.  K15 trimethylation is demonstrated by ion pairs y4-y7 and b5-b8, and K17 trimethylation is demonstrated 
by ion pairs y2-y4 and b9-b10.  The presence of the MH+-59 supports the assignment of trimethylation.  m/z 646.62+; 






























































































G Kme3 G Kac R P P G Q T T K
                    y10                 y8    y7   y6                  y3  y2  
                     b2   b3           b4   b5         b8   b9   b10 b11
Figure 5.6F.  Sequencing of H2Bv trytic peptide 16-27 (GKGKRPPGQTTK) shows that K17 is trimethylated and K19 is 
acetylated.  The b2 ion demonstrates that K17 is trimethylated, and the b3-b4 and y8-y10 ion pairs show that K19 is 

































































































G Kac R P P G Q T T K
y9           y8   y7          y5           y3   y2  
               b2   b3                 b6     b7   b8  b9
Figure 5.6G.  H2Bv tryptic peptide 18-27 (GKRPPGQTTK) was sequenced, and b2 and y8-y9 ions demonstrate that K19 
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which results from tryptic cleavage of ubiquitin.  Although a targeted search for 
the ubiquitinated H2Bv peptide 126-134 (AVAKYNASR) containing lysine 129 
was performed on all 8 gel slices, no evidence of H2Bv ubiquitination was found.   
There were two factors preventing us from concluding that H2Bv was not 
ubiquitinated.  First, a single ubiquitin tryptic peptide was identified in gel slices 
#6 and 7, which ranged from ~25 to 32 kDa.  Second, H2Bv tryptic peptides were 
found in gel slices #6 and 7 as well.  This suggests that ubiquitinated H2Bv could 
be present, but was not identified by these methods.  Also, it was possible that 
the IgG light chain (25 kDa) was co-migrating with ubiquitinated H2Bv (25.1 kDa).  
IgG was a darker band than the unmodified H2Bv and would certainly suppress 
the signal of a minor modified H2Bv species.  Therefore, an independent method 
would be required to verify that H2Bv was not ubiquitinated. 
 
Western Blot Analysis of Purified H2Bv-FLAG 
 
To further test whether H2Bv-FLAG was or was not ubiquitinated, purified 
material was analyzed on a Western blot using an anti-ubiquitin antibody (Fig. 
5.7).  To avoid contaminating the sample with IgG from the anti-FLAG M2 affinity 
resin, H2Bv-FLAG was eluted with FLAG peptide instead of boiling the resin in 
SDS-PAGE loading buffer.  This resulted in a much lower yield because only 
~10% of the bound material eluted with FLAG peptide.  Immunoprecipitated 
H2Bv-FLAG from 2.0x108 cells was analyzed on a blot alongside purified  
Figure 5.7.  Histone H2B variant is not ubiquitinated.  Purified ubiquitin (Sigma), 
cell lysate from a cell line containing FLAG-tagged H2Bv, and 
immunoprecipitated H2Bv-FLAG are analyzed on a Western blot.  Incubating the 
blot with anti-ubiquitin antibody (P4D1 from Santa Cruz Biotechnology) 
demonstrates that this antibody recognizes trypanosome ubiquitin (8.4 kDa) in 
the cell lysate lane.  The lane containing immunoprecipitated H2Bv-FLAG from 
2.0x108 cells does not have ubiquitinated proteins.  The cell lysate and 
immunoprecipitated H2Bv-FLAG from 2.0x107 cells are also probed with 
anti-FLAG antibody to show that FLAG-tagged H2Bv (16.7 kDa) is present in the 
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ubiquitin and cell lysate from cells containing FLAG-tagged H2Bv.  The blot 
shows no evidence of ubiquitinated proteins in the H2Bv-FLAG purification.  The 
signal below 10 kDa in the cell lysate lane is presumably ubiquitin itself, which 
demonstrates that the antibody recognizes trypanosome ubiquitin.  A smear of 
bands in the higher molecular weight range suggests that there are many 
ubiquitinated proteins in T. brucei.  This becomes more evident when more cell 
lysate is loaded or the exposure time is increased. 
Based on the MS and Western analysis of purified H2Bv-FLAG, I 
concluded that H2Bv is not ubiquitinated. 
 
H3 K4 and K76 Methylation is enriched in H2Bv-containing Nucleosomes 
 
Although there was no evidence of H2Bv ubiquitination, I continued to 
pursue the hypothesis that H2Bv affected H3 K4 and K76 methylation.  Both H3 
methyl marks could be assayed using specific antibodies.  H3 K76 methylation 
was evaluated using an H3K76me3-specific antibody that was characterized 
previously [166].  
To investigate whether H2Bv specifically co-localized with H3 that is 
methylated at K4 and K76, I prepared mononucleosomes from cell lines 
containing FLAG-tagged H2B or H2Bv (Fig. 5.8A).  Mononucleosomes were 
immunoprecipitated with anti-FLAG affinity resin, and H2B- and H2Bv-containing 






































































H2B-FLAG  H2Bv-FLAG parental cells
Figure 5.8.  Histone H2Bv co-immunoprecipitates with Histone H3 that is 
trimethylated at lysines 4 and 76.  (A)  DNA extracted from the nucleosomes 
(prepared from cell lines containing FLAG-tagged H2B or H2Bv) is 
approximately 150 bp, demonstrating that mononucleosomes were prepared.  
(B)  Mononucleosomes were immunoprecipitated with anti-FLAG affinity resin 
and evaluated by Western blot with anti-H3K4me3 and K76me3 antibodies.  
H2Bv-containing mononucleosomes were highly enriched for H3 that is 
trimethylated at K4 compared to H2B-containing mononucleosomes.  
H2Bv-containing mononucleosomes were slightly, but reproducibly, enriched for 
H3 that is trimethylated at K76.  The general anti-H3 antibody demonstrates that
the immunoprecipitate was loaded equally in the H2B and H2Bv lanes.
B.
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specific antibodies (Fig. 5.8B).  H2Bv-containing mononucleosomes were highly 
enriched for H3 K4 methylation compared to H2B-containing mononucleosomes.  
H2Bv-containing mononucleosomes were also slightly, but very reproducibly, 
enriched for H3 K76 methylation.  A general H3 antibody showed that the amount 
of H3 loaded from the H2B and H2Bv immunoprecipitate was approximately 
equal.   
These results showed that there was a specific association between H2Bv 
and trimethyl H3 K4 and K76.  This was consistent with the relationship observed 
in yeast between the H2B C-terminus and H3 K4 and K79 methylation, although, 
because I have shown that H2Bv is not ubiquitinated, it is clear that T. brucei 
H2Bv affects H3 methylation by an independent pathway. 
 
H2Bv K129 does not affect H3 K4 or K76 Methylation 
 
To investigate whether H2Bv K129 played a role in the enrichment of H3 
K4 and K76 methylation in H2Bv-containing mononucleosomes, K129 was 
mutated to alanine (K129A) or arginine (K129R).  Cell lysate from cell lines that 
replaced the two endogenous h2bv alleles with FLAG-tagged H2Bv K129A or 
K129R was collected and analyzed by Western blot using the H3K4me3- and 
H3K76me3-specific antibodies (Fig. 5.9).  Mutation of H2Bv K129 appeared to 
have no effect on the level of H3 K4 and K76 methylation compared to wildtype 




























































h2bv sko    h2bv dko
Figure 5.9.  Mutation of histone H2Bv lysine 129 does not interfere with H3 
lysine 4 or 76 methylation.  Cell lines with ectopic copies of FLAG-tagged H2Bv 
wt, H2Bv K129A, or H2Bv K129R were introduced in h2bv single knockout (sko) 
or double knockout (dko) backgrounds.  Cell lysate from these cell lines were 
loaded on a Western blot and probed with anti-FLAG, anti-H3K4me3, 
anti-H3K76me3, and anti-H3 antibodies.  H2Bv K129 mutants did not 
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ubiquitinated, so I concluded that H2Bv K129 does not play a role homologous to 
yeast H2B K123. 
Next, I collected mononucleosomes containing FLAG-tagged H2Bv K129A 
and K129R and immunoprecipitated them with anti-FLAG affinity gel.  Mutation of 
H2Bv K129 did not prevent enrichment of H3 K4 and K76 methylation in H2Bv-
containing nucleosomes (Fig. 5.10).  These results show that H2Bv lysine 129 is 
not involved in co-localization of H2Bv with methylated H3. 
 
The C-terminus of H2Bv is Essential 
 
T. brucei H2B and H2Bv share significant sequence homology at the C-
terminus, except for the last 5-15 amino acids. I hypothesized that the H2Bv C-
terminal tail might be responsible for the enrichment of H3 methylation in H2Bv-
containing mononucleosomes, even if K129 was not.  The N-terminus and core 
domain of the two histones share minimal sequence homology, so it is also 
possible that these domains might be responsible for the co-immunoprecipitation 
results, but I did not pursue this further.  
To study the relationship between the H2Bv C-terminal tail and H3 
methylation, a FLAG-tagged H2Bv mutant was made in which the C-terminal tail 
(5´ –AKYNASREEAYSKVL) was removed.  Unusually, when the FLAG-tagged 
H2BvΔCTD mutant replaced one allele of endogenous h2bv, the FLAG fusion 
protein was not observed in any of the four clones (Fig. 5.11).  Proper integration  
Figure 5.10.  Mutation of histone H2Bv lysine 129 does not prevent H3 that is
methylated at K4 and K76 from co-immunoprecipitating with H2Bv.  (A)  
Mononucleosomes were prepared from cell lines with FLAG-tagged H2B, H2Bv,
H2Bv K129A, and H2Bv K129R.  DNA was extracted from the mononucleosomes
and analyzed on an agarose gel.  (B)  Mononucleosomes were 
immunoprecipitated on anti-FLAG resin and analyzed by Western blot with anti-
H3K4me3, H3K76me3, and H3 antibodies.  Immunoprecipitate from H2Bv K129
mutants showed no change in the level of H3 K4 and K76 methylation associated
















































































































































Figure 5.11.  Deletion of the C-terminal tail of histone H2Bv lysine 129 does not 
interfere with H3 lysine 4 or 76 methylation.  In h2bv single knockout (sko) cells, 
an ectopic copy of FLAG-tagged H2Bv lacking its C-terminal tail (H2Bv∆CTD) 
was introduced, and cell lysate was collected from four representative clones.  
These cell lysates were analyzed by Western blot using anti-FLAG, 
anti-H3K4me3, anti-H3K76me3, and anti-H3 antibodies.  H2Bv∆CTD mutants 
did not express their FLAG fusion protein. These mutants did not demonstrate 
any change in H3 K4 or K76 methylation compared to wildtype H2Bv.
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of the mutant was confirmed by sequencing.  The ectopic copy of H2Bv was 
downstream of an inducible T7 promoter, so the H2Bv mutant must be 
transcribed by the T7 polymerase, and either the mRNA or protein is rapidly 
degraded.  This is an interesting result because, even though an endogenous 
copy of h2bv is present, the cell will not tolerate the presence of the H2Bv 
mutant, suggesting that the C-terminal tail plays an essential role in the 
nucleosome.  Also, the second allele of h2bv could not be replaced, confirming 
that the C-terminal tail of H2Bv is essential. 
 
Discussion   
 
The remarkable sequence conservation between T. brucei H2Bv and the 
H2B consensus sequence led to our initial hypothesis that lysine 129 was 
ubiquitinated and required for H3 K4 and K76 methylation.  Ubiquitinated 
histones are frequently present in low abundance, so they may be overlooked 
when performing a survey of histone PTMs by MS.  However, I performed a 
targeted MS search for ubiquitinated H2Bv K129 by specifically enriching for the 
mass corresponding to the theoretical mass of ubiquitinated H2Bv peptide 126-
134.  The presence of a single ubiquitin peptide in gel slices #6 and 7 was most 
likely due to ubiquitinated H2A, a PTM that was identified in a previous chapter.  
H2A co-immunoprecipitated with H2Bv and was also found migrating in a higher 
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molecular weight range (25-32 kDa) than would be expected based on its 
molecular weight (14.1 kDa). 
I also analyzed purified H2Bv-FLAG by Western blot with an anti-ubiquitin 
antibody and found there were no bands present corresponding to ubiquitinated 
H2Bv.  Both methods enabled us to conclude that H2Bv K129 is not 
ubiquitinated.  This is supported by the observation that mutation of K129 is 
completely acceptable to the cells and does not disrupt H3 K4 or K76 
methylation.  These experiments show that H2Bv K129 does not play a role 
homologous to yeast H2B K123, despite the sequence similarities.   
Although our original hypothesis proved to be incorrect, I was able to 
show, using specific antibodies, that H2Bv was found in mononucleosomes 
enriched for H3 K4 and K76 methylation.  H3 K4 and K76 methylation are 
typically associated with transcriptionally active chromatin, although this 
relationship has not been demonstrated in trypanosomes [196].  Based on our 
results, I hypothesized that H2Bv replaces H2B in nucleosomes, which then 
permits H3 K4 and K76 to be methylated.  Replacing modified canonical histones 
with histone variants may be a mechanism for relieving transcriptional repression 
and would be in keeping with one of the roles of histone variants in other 
organisms. 
 Previous work on T. brucei H2Bv and histone variant H2AZ showed that 
the two variants co-immunoprecipitate in the same nucleosome [174].  H2AZ 
does not co-immunoprecipitate with canonical H2A or H2B, suggesting that 
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nucleosomes containing H2Bv consist of two H2AZ/H2Bv dimers.  As an 
extension of our previous hypothesis, perhaps H2AZ/H2Bv dimers replace 
canonical H2A/H2B dimers in the nucleosome as a mechanism for relieving 
transcriptional repression.  Canonical H2A and H2B may repress transcription or 
may simply prevent H3 from being methylated at sites associated with active 
transcription.  In this way, histone variants may play a role in the regulation of 
gene expression in trypanosomes. 
The same study showed that H2AZ and H2Bv did not co-localize with sites 
of active transcription, which were visualized by BrUTP incorporation [174].  
However, the authors suggest that perhaps the H2AZ/H2Bv-containing 
nucleosomes are localized to the promoter regions of active genes and are 
displaced during transcription by RNA polymerase II, so the variants may not be 
readily visible at actively transcribed chromatin.  It seems unlikely, although still a 
possibility, that H2Bv would be found in nucleosomes enriched for H3 K4 and 
K76 methylation, marks traditionally associated with transcriptional activity, and 
would not be present at sites of active transcription. 
Since H2AZ and H2BV appear to be present in the same nucleosome, 
another alternative pathway leading to H3 K4 and K76 methylation could involve 
ubiquitination at the H2AZ C-terminus.  Like canonical H2A, trypanosome H2AZ 
has 6 lysines at its C-terminus.  However, none of these aligns with the 
ubiquitinated H2A K119 observed in other organisms (discussed in Chapter 3).  
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This hypothesis can be readily addressed by epitope-tagging and purifying H2AZ 
and analyzing the sample by Western blot with a ubiquitin antibody and MS. 
 H2Bv is an essential gene.  A deletion mutant of the first 23 amino acids of 
H2Bv was viable, indicating that the N-terminus is not essential [174].  A FLAG-
tagged H2Bv mutant in which C-terminal residues 128-142 were removed was 
not expressed in an h2bv single knockout background.  The second allele of 
h2bv could not be removed in this cell line, which illustrates that residues 128-
142 are essential.  It is difficult to draw any conclusions concerning the role of a 
mutation when the phenotype is lethality, but I hypothesized that residues 128-
142 are involved in the enrichment of H3 methylation in H2Bv-containing 
nucleosomes.  I based this hypothesis on the conservation of some residues in 
the H2Bv C-terminal tail with H2B in other organisms, but also on the absence of 
sequence homology between T. brucei H2B and H2Bv C-terminal tails when the 
remainder of the C-terminus is highly conserved.  Although the mechanism has 
not been delineated, it is clear that trypanosome H3 K4 and K76 methylation are 
governed by a different pathway than what is observed in yeast. 
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Chapter 6.  Conclusions 
 
Future Steps in Trypanosome Chromatin Biology 
 
 A comprehensive list of PTMs on the four core histones provides a 
necessary starting point for the study of chromatin in T. brucei.  Based on this 
information, additional approaches may be established to aid in understanding 
the relationship between chromatin structure and gene expression in 
trypanosomes.  
 Site-Directed Mutagenesis of H3 and H4.  One approach to determining 
how various PTMs are involved in gene expression or other biological processes 
would be to introduce point mutations in the amino acids of interest and assay for 
a phenotype.  Our lab has chosen to focus on histones H3 and H4.  Both H3 and 
H4 are present in tandem arrays, which must be deleted and replaced with a 
single ectopic copy of each gene. The ectopic copies should be introduced with 
endogenous UTRs because the expression of at least one histone has been 
shown to be cell cycle regulated [197].  Also, H3 and H4 would probably need to 
be introduced downstream of an inducible T7 promoter so that they may be 
expressed at levels comparable to their expression level in wild-type cells.  In 
yeast and other organisms, the N-termini of these histones have been shown to 
be functionally redundant in some cases, so it would be preferable to make one 
cell line in which both H3 and H4 were present in single copies.  For example, if a 
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single point mutation in H4 did not demonstrate a phenotype, the N-terminus of 
H3 could be deleted to determine if it was functionally redundant to H4.  With this 
cell line, point mutations in the modified amino acids could be assayed for 
specific phenotypes, including de-repression of VSG silencing at the inactive ES. 
 Histone modifying enzymes.  A number of putative histone modifying 
enzymes have been identified in the trypanosome genome project, some of 
which are beginning to be characterized (see Chapter 1)[148].  Determining 
which histone modifying enzyme creates each PTM could be a straightforward 
endeavor.  For non-essential enzymes, histones would be purified from knockout 
cell lines according to the protocol described in Chapter 3.  Alternatively, if an 
enzyme is essential, an RNAi knockdown construct could be created.  Purified 
histones could then be modified with deuterated propionic acid, mixed with 
propionylated histones from wt BF or PF, and trypsinized.  Changes in the 
abundance of PTMs in mutant cells could be determined by comparing the 
intensity of their corresponding MALDI-TOF peaks to wt peaks.  Also, if specific 
antibodies were available, mutant cell lines could be more easily tested by 
Western blot. 
 Once the targets of histone modifying enzymes have been identified, 
deletion mutants of the enzymes or histone target mutations could be studied for 
defects in lifecycle stage differentiation, cell cycle progression, ES silencing, and 
non-ES transcriptional silencing and activation.  The resulting data, and the 
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phenotypes of mutagenized cells described above, could be used to determine 
which histone PTMs are involved in these biological processes.   
 Specific antibodies.  Antibodies specific for histone PTMs would be 
valuable tools for studying marks that have interesting preliminary functional 
data.  They may be used for analysis by Western blot, immunofluorescence, and 
chromatin immunoprecipitation.  I previously established that commercially 
available antibodies are not specific for divergent trypanosome histones, so 
antibodies must be raised against modified trypanosome peptides and rigorously 
purified and validated.   
PTM-binding proteins.  The downstream biological effects of histone 
PTMs are mediated through the binding of effector proteins [2].  In order to 
identify effector proteins that bind PTMs on trypanosome histones, modified 
trypanosome peptides may be used for affinity purification of binding partners 
from trypanosome cell extracts.  These proteins may be resolved by SDS-PAGE 
and identified by MS.  Effector proteins must be distinguished from proteins that 
bind the unmodified peptide, although proteins that bind the unmodified peptide, 
but not the modified peptide, may also be of interest.  The epitope-tagged 
effector protein may also be used to pulldown additional proteins that potentially 
act together in a complex.  Finally, PTM-binding proteins may be deleted to 
determine which biological processes are affected.  
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Antigenic Variation 
 
 Heterochromatin formation at the 3´ end of inactive ES may be involved in 
prohibiting transcription by RNA pol I, which initiates transcription at many ES, 
but only transcribes to the 3´ end of a single ES [111].  The two pathways of 
heterochromatin assembly described in Chapter 1, mediated by HP1 and SIR2, 
do not appear to be involved in ES silencing.  HP1 and H3 K9 do not have 
homologues in trypanosomes.  A SIR2-related protein, TbSIR2RP-1, plays a role 
in establishing telomeric silencing at non-ES loci, but not at ES loci [170].  
Perhaps a novel pathway is responsible for heterochromatin assembly at the ES.  
The tools described above may help determine whether histone PTMs, histone 
modifying enzymes, and effector proteins are involved in establishing 
transcriptionally restrictive or permissive chromatin at the ES. 
 It should be noted that heterochromatin formation is not the only 
mechanism thought to be regulating ES silencing.  As mentioned in Chapter 1, 
the active ES is localized to the ESB, so expulsion of the inactive ES from the 
ESB may also inhibit transcription of these loci.  This is important because some 
studies have already been published in which deletion of factors, including 
histone modifying enzymes, have been assayed for de-repression of the inactive 
ES, but no major effects on ES silencing have been observed.  These factors 
may be involved in heterochromatin formation, which could be inhibited in 
deletion mutants, but the inactive ES in the mutants would still not have access to 
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factors required to promote transcription to the 3´ end of the ES, so no ES 
phenotype would be readily observed.  Therefore, better assays must be devised 
to test a candidate protein for involvement in ES silencing. 
In order to better understand what makes the ESB the exclusive site of 
VSG transcription, we should first identify the factors that comprise the ESB.  It is 
predicted that the ESB will contain both elongation factors and RNA processing 
machinery, since it was shown that only transcripts from the active ES were 
properly processed [111].  Elongation factors in other organisms include PTM-
binding effector proteins and histone modifying enzymes, so these should be 
epitope-tagged in trypanosomes and visualized by immunofluorescence for 
localization to the ESB.  This would provide a number of candidates that could be 
involved in ES transcription regulation, although this approach might be 
challenging if the critical factors are present in very small quantities. 
 
Conservation in an Evolutionarily Divergent Organism 
 
 In the previous chapter, I showed that H2Bv shared significant sequence 
homology with yeast H2B and is present in nucleosomes enriched for H3 K4 and 
K76 methylation.  However, ubiquitination of the H2Bv C-terminus was not 
required for this enrichment.  I propose that, while mechanisms of histone cross-
talk are not conserved, the same endpoint is achieved in both organisms.  In 
yeast, H2B K123 ubiquitination acts as a trigger for downstream events that 
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include H3 K4 and K79 methylation, all of which are associated with transcription 
elongation.  In trypanosomes, perhaps the same trigger is achieved by replacing 
H2A/H2B dimers with H2AZ/H2Bv dimers in nucleosomes.  The H2AZ/H2Bv 
dimers may act to relieve repression imposed by H2A/H2B or may somehow 
actively facilitate H3 K4 and K76 methylation.  H2AZ and H2BV share 43% and 
38% sequence identity with T. brucei H2A and H2B, respectively [174].  
Sequences that diverge between the variant and its corresponding major histone 
may be sufficient to induce H3 methylation, even in the absence of ubiquitination.  
Based on our data and sequence alignments, a likely sequence candidate would 
be the C-terminal tail of H2BV (aa 128-142), which is essential. 
 There are three components to our model, all of which can be addressed.  
First, I propose that the H2Bv/H2AZ dimer is deposited in the nucleosome in a 
replication-independent manner.  There is ample support for replication-
independent deposition of histone variants in the literature.  FLAG-tagged H2Bv 
could be used to pulldown interacting proteins, which could be identified by MS.  
Putative chromatin remodeling factors or histone chaperones would make 
excellent candidates; these, in turn, could be deleted to look for defects of 
H2Bv/H2AZ incorporation into the nucleosome.   
Second, I propose that H2Bv/H2AZ deposition allows for H3 K4 and K76 
methylation.  This process may be mediated through the C-terminal tail of H2Bv.  
In addition to possessing several conserved residues from the yeast H2B C-
terminus, the C-terminal tail is a good candidate because the crystal structure of 
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the nucleosome predicts that it is in close proximity to H3 K76, which would 
facilitate interactions between the two domains [198].  Introducing an ectopic 
copy of H2B with the H2Bv C-terminal tail may result in enrichment of H3 K4 and 
K76 methylation in H2B-containing nucleosomes.  This would show that the 
H2Bv C-terminal tail was sufficient to direct H3 K4 and K76 methylation.   
Third, I propose that H3 K4 and K76 methylation is associated with 
actively transcribed chromatin.  Chromatin immunoprecipitation using specific 
antibodies against trimethyl H3 K4 and K76 could show whether these marks are 
associated with transcriptionally active loci.  Primers against active and inactive 
VSGs could be used to distinguish transcriptionally active and silent loci, but loci 
that are transcribed by RNA pol II should also be examined.  
 Our efforts to study chromatin in trypanosomes illustrate that, while some 
histone sequences and posttranslational modifications are conserved, the 
functional relationships between marks may not be.  Work in divergent organisms 
will help to define some of the general principles underlying chromatin biology. 
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